Faculty of Engineering, LTH

Denna sida på svenska This page in English

Literature references 2005-


  1. Björnsson B, Borrebaeck C, Elander N, Gasslander T, Gawel DR, Gustafsson M, Jörnsten R, Lee EJ, Li X, Lilja S, Martínez-Enguita D, Matussek A, Sandström P, Schäfer S, Stenmarker M, Sun XF, Sysoev O, Zhang H, Benson M (2020) Digital twins to personalize medicine. Genome Med 12, 4 (Abstract)
  2. Lees W, Busse CE, Corcoran M, Ohlin M, Scheepers C, Matsen FA IV, Yaari G, Watson CT, The AIRR Community, Collins A, Shepherd A (2020) OGRDB – a reference database of inferred immune receptor genes. Nucleic Acids Res 48, D964–D970. (Abstract)
  3. Ljungars A, Schiött T, Mattson U, Steppa J, Hambe B, Semmrich M, Ohlin M, Tornberg UC, Mattsson M (2020) A bispecific IgG format containing four independent antigen binding sites. Sci Rep 10, 1546. (Abstract)
  4. Lindberg T, de Ávila RI, Zeller KS, Levander F, Eriksson D, Chawade A, Lindstedt M (2020) An integrated transcriptomic- and proteomic-based approach to evaluate the human skin sensitization potential of glyphosate and its commercial agrochemical formulations. J Proteomics 217, 103647 (Abstract)
  5. Willforss J, Leonova S, Tillander J, Andreasson E, Marttila S, Olsson O, Chawade A, Levander F (2002) Interactive proteogenomic exploration of response to Fusarium head blight in oat varieties with different resistance. J Proteomics (in press) (Abstract)
  6. Niksirata H,Levander F,Koubaa A, James P (2020) Proteomic changes after fertilization and before first cleavage in rainbow trout Oncorhynchus mykiss. Aquaculture 520, 734951. (Abstract)
  7. Smakaj E, Babrak L, Ohlin M, Shugay M, Briney B, Tosoni D, Galli C, Grobelsek V, D’Angelo I, Olson B, Watson C, Reddy S, Greiff V, Trück J, Marquez S, Lees W, Miho E (2020) Benchmarking immunoinformatic tools for the analysis of antibody repertoire sequences. Bioinformatics 36, 1731–1739. (Abstract)
  8. Gray AC, Bradbury A, Dübel S, Knappik A, Plückthun A, Borrebaeck CAK (2020) Reproducibility: bypass animals for antibody production. Nature (in press) (Full text)
  9. Eskes C, Alves PM, Clewell R, Corsini E, Cotgreave I, Kopp-Schneider A, Navas Antón JM, Piersma A, Westmoreland C, Borrebaeck C, Bradbury A, Dübel S, Gray A, Knappik HJ, Plückthun A (2020) On the Scientific validity of replacements for animal-derived antibodies. In: Halder M, Barroso J, Whelan M. EURL ECVAM recommendation on non-animal-derived antibodies. Annex 1 (Full report)
  10. Clewell C, Westmoreland C, Borrebaeck C, Bradbury A, Dübel S, Gray A, Knappik HJ, Plüchthun A (2020) ESAC working group report on the scientific validity of replacements for animal-derived antibodies. In: Halder M, Barroso J, Whelan M. EURL ECVAM recommendation on non-animal-derived antibodies. Annex 2. (Full report)
  11. Velickovic K, Rahm Hallberg I, Axelsson U, Borrebaeck CAK, Rydén L, Johnsson P, Månsson J (2020) Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden. Health Qual Life Outcomes 18, 132. (Abstract)


  1. Brix DM, Tvingsholm SA, Hansen MB, Clemmensen KB, Ohman T, Siino V, Lambrughi M, Hansen K, Puustinen P, Gromova I, James P, Papaleo E, Varjosalo M, Moreira J, Jäättelä M, Kallunki T (2019) Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion. Oncogene 38, 3170-3184. (Abstract)
  2. Grundström G, Borrebaeck CAK (2019) Skin Sensitization Testing-What's Next?. Int J Mol Sci 20, 666. (Abstract)
  3. Nilsson JS, Abolhalaj M, Lundberg K, Lindstedt M, Greiff L (2019) Dendritic cell subpopulations in nasopharyngeal cancer. Oncol Lett 17, 2557-2561. (Abstract)
  4. Ohlin M, Scheepers C, Corcoran M, Lees WD, Busse CE, Bagnara D, Thörnqvist L, Bürckert LP, Jackson KJL, Ralph DK, Schramm CA, Marthandan N, Breden F, Scott JK, Matsen IV FA, Greiff V, Yaari G, Kleinstein SH, Christley S, Sherkow JS, Kossida S, Lefranc MP, van Zelm MC, Watson CT, Collins AM (2019) Inferred allelic variants of immunoglobulin receptor genes: a system for their evaluation, documentation and naming. Front Immunol 10, 435. (Abstract)
  5. Gradin R, Lindstedt M, Johansson H (2019) Batch adjustment by reference alignment (BARA): Improved prediction performance in biological test sets with batch effects. PLoS One 14, e0212669. (Abstract)
  6. Liljedahl L, Pedersen MH, McGuire JN, James P (2019) The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome.  Physiol Rep 7, e13994. (Abstract)
  7. Papakonstantinou N, Ntoufa S, Tsagiopoulou M, Moysiadis T, Bhoi S, Malousi A, Psomopoulos F, Mansouri L, Laidou S, Papazoglou D, Gounari M, Pasentsis K, Plevova K, Kuci-Emruli V, Duran-Ferrer M, Davis Z, Ek S, Rossi D, Gaidano G, Ritgen M, Oscier D, Stavroyianni N, Pospisilova S, Davi F, Ghia P, Hadzidimitriou A, Belessi C, Martin-Subero JI, Pott C, Rosenquist R, Stamatopoulos K (2019) Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. Int J Cancer 144, 2695-2706. (Abstract)
  8. Marcišauskas S, Ulfenborg B, Kristjansdottir B, Waldemarson S, Sundfeldt K (2019) Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2. J Proteomics 196, 57-68. (Abstract)
  9. Stenman E, Palmér K, Rydén S, Sävblom C, Svensson I, Rose C, Ji J, Nilbert M, Sundquist J (2019) Diagnostic spectrum and time intervals in Sweden’s first diagnostic center for patients with nonspecific symptoms of cancer. Acta Oncol 58, 296-305. (Abstract)
  10. de Ávila RI, Veloso DFMC, Teixeira GC, Rodrigues TL, Lindberg T, Lindstedt M, Fonseca SG, Lima EM, Valadares MC (2019) Evaluation of in vitro testing strategies for hazard assessment of the skin sensitization potential of "real-life" mixtures: the case of henna-based hair coloring products containing p-phenylenediamine. Contact Dermatitis 81, 194-209. (Abstract)
  11. Lindberg T, Forreryd A, Bergendorff O, Lindstedt M, Zeller KS  (2019) In vitro assessment of mechanistic events induced by structurally related chemical rubber sensitizers. Toxicol in Vitro 60 144-153. (Abstract)
  12. Ljungars A, Svensson C, Carlsson A, Birgersson E, Tornberg U-C, Frendéus B, Ohlin M, Mattsson M (2019) Deep mining of complex antibody phage pools generated by cell panning enables discovery of rare antibodies binding new targets and epitopes. Front Pharmacol 10, 847 (Abstract)
  13. Rojas-Macias MA, Mariethoz J, Andersson P, Jin C, Venkatakrishnan V, Aoki NP, Shinmachi D, Ashwood C, Madunic K, Zhang T, Miller RL, Horlacher O, Struwe WB, Watanabe Y, Okuda S, Levander F, Kolarich D, Rudd PM, Wuhrer M, Kettner C, Packer NH, Aoki-Kinoshita KF, Lisacek F, Karlsson NG (2019) Towards a standardized bioinformatics infrastructure for N- and O-glycomics. Nat Commun 10, 3275. (Abstract)
  14. Sapir T,  Segal M,  Grigoryan G, Hansson KM, James P, Segal M, Reiner O (2019) The interactome of Palmitoyl-Protein Thioesterase 1 (PPT1) affects neuronal morphology and function. Front Cell Neurosci 13, 92. (Abstract)
  15. Forreryd A, Johansson H, Lindberg T, Zeller K, Lindstedt M (2019) Letter to the editor regarding the article "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination". Regul Toxicol Pharmacol 107, 104439. (Abstract)
  16. Albertsson-Lindblad A, Freiburghaus C, Jerkeman M, Ek S (2019) Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide. Exp Hematol Oncol 8, 16. (Abstract)
  17. Glesner J, Kapingidza AB, Godzwon M, Offermann LR, Mueller GA, DeRose EF, Wright P, Richardson CM, Woodfolk JA, Vailes LD, Wunschmann S, London RE, Chapman MD, Ohlin M, Chruszcz M,  Pomes A (2019) A human IgE antibody binding site on Der p 2 for the design of recombinant allergen for immunotherapy. J Immunol 203, 2545-2556. (Abstract)
  18. de Ávila RI, Lindstedt M, Valadares MC (2019) The 21st Century movement within the area of skin sensitization assessment: From the animal context towards current human-relevant in vitro solutions. Regul Toxicol Pharmacol 108, 104445. (Abstract)
  19. Resjö S, Zahid MA, Burra DD, Lenman M, Levander F, Andreasson E (2019) Proteomics of PTI and Two ETI Immune Reactions in Potato Leaves. Int J Mol Sci 20, 4726. (Abstract)
  20. Nilsson JS, Forslund O, Andersson FC, Lindstedt M, Greiff L (2019) Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer. Sci Rep 9, 15432. (Abstract)
  21. Axelsson U, Månsson J, Johnsson P, Borrebaeck CAK, Rydén L, Edén P, Rahm Hallberg I (2019) A scoping review exploring psychological resilience in relation to various biomolecular variables. Biomed J Sci & Tech Res 23, 17733-17743.


  1. Zeller KS, Johansson H, Lund TØ, Kristensen NN, Roggen EL, Lindstedt M. (2018) An alternative biomarker-based approach for the prediction of proteins known to sensitize the respiratory tract. Toxicol In Vitro 46 155-162. (Abstract)
  2. Forreryd A, Norinder U, Lindberg T, Lindstedt M (2018) Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARD. Toxicol In Vitro 48, 179-187. (Abstract)
  3. Thörnqvist L, Ohlin M (2018) The functional 3´-end of immunoglobulin heavy chain variable (IGHV) genes. Mol Immunol 96, 61-68. (Abstract)
  4. Thörnqvist L, Ohlin M (2018) Data on the nucleotide composition of the first codons encoding the complementary determining region 3 (CDR3) in immunoglobulin heavy chains. Data Brief 19, 337-352. (Abstract)
  5. Säll A, Corbee D, Vikström S, Ottosson F, Persson H, Waldemarson S (2018) Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range. PLoS One 13, e0189116. (Abstract)
  6. Abbruzzese JL, Andersen DK, Borrebaeck CAK, Chari ST, Costello E, Cruz-Monserrate Z, Eibl G, Engleman EG, Fisher WE, Habtezion A, Kim SK, Korc M, Logsdon C, Lyssiotis CA, Pandol SJ, Rustgi A, Wolfe BM, Zheng L, Powers AC. (2018) The interface of pancreatic cancer with diabetes, obesity, and inflammation: Research gaps and opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Pancreas 47, 516-525. (Abstract)
  7. Freiburghaus C, Emruli VK, Johansson A, Eskelund CW, Grønbæk K, Olsson R, Ek F, Jerkeman M, Ek S (2018) Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity. BMC Cancer 18, 466. (Abstract)
  8. Abolhalaj M, Askmyr D, Sakellariou C, Lundberg K, Greiff L, Lindstedt M (2018) Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils. Sci Rep 8, 8030. (Abstract)
  9. Persson H, Kirik U, Thörnqvist L, Greiff L, Levander F, Ohlin M (2018) In vitro evolution of antibodies inspired by in vivo evolution. Front Immunol 9, 1391. (Abstract)
  10. Siino V, Amato A, Di Salvo F, Caldara GF, Filogamo M, James P, Vasto S (2018) Impact of diet-induced obesity on the mouse brain phosphoproteome. J Nutr Biochem 58, 102-109. (Abstract)
  11. Björner S, Rosendahl AH, Tryggvadottir H, Simonsson M, Jirström K, Borgquist S, Rose C, Ingvar C, Jernström H (2018) Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy treatment. Front Endocrinol 9, 306. (Abstract)
  12. Wisse A, Tryggvadottir H, Simonsson M, Isaksson K, Rose C, Ingvar C, Jernström H (2018) Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis. Cancer Causes Control 29, 643–656. (Abstract)
  13. Devito C, Ellegård R, Falkeborn T, Svensson L, Ohlin M, Larsson M, Broliden K, Hinkula J (2018) Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro. Sci Rep 8, 10180. (Abstract)
  14. Andreasson Axelsson U, Rydén L, Johnsson P, Edén P, Månsson J, Rahm Hallberg I, Borrebaeck CAK (2018) Study protocol - SCAN-B Resilience a multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients. BMC Cancer 18, 789. (Abstract)
  15. van Leeuwen-Kerkhoff N, Lundberg K, Westers TM, Kordasti S, Bontkes HJ, Lindstedt M, de Gruijl TD, van de Loosdrecht AA (2018) Human bone marrow-drived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes Front Immunol 9, 1619. (Abstract)
  16. Mellby LD, Nyberg AP, Johansen JS, Wingren C, Nordestgaard BG, Bojesen SE, Mitchell BL, Sheppard BC, Sears RC, Borrebaeck CAK (2018) Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer. J Clin Oncol 36, 2887-2894. (Abstract)
  17. Thörnqvist L, Ohlin M (2018) Critical steps for computational inference of the 3’-end of novel alleles of immunoglobulin heavy chain variable genes – illustrated by an allele of IGHV3-7. Mol Immunol 103, 1-6. (Abstract)
  18. Braekeveldt N, von Stedingk K, Fransson S, Martinez-Monleon A, Lindgren D, Axelson H, Levander F, Willforss J, Hansson K, Øra I, Backman T, Börjesson A, Beckman S, Esfandyari J, Berbegall AP, Noguera R, Karlsson J, Koster J, Martinsson T, Gisselsson D, Påhlman S, Bexell D (2018) Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma. Cancer Res 78, 5958-5969. (Abstract)
  19. Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg UC, Jansson B, Persson N, Kuci Emruli V, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I, Mattsson M (2018) Phenotypic discovery of therapeutic antibodies and targets for cancer treatment. NPJ Precis Oncol 2, 18. (Abstract)
  20. Hu FJ, Volk AL, Persson H, Säll A, Borrebaeck C, Uhlén M, Rockberg J  (2018) Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders. New Biotechnol 45, 80-88. (Abstract)
  21. Petersson F, Kilsgård O, Shannon O, Lood R (2018)  Platelet activation and aggregation by the opportunistic pathogen Cutibacterium (Propionibacterium) acnes. PLoS One 13, e0192051. (Abstract)
  22. Willforss J, Chawade A, Levander F (2018) NormalyzerDE: Online tool for improved normalization of omics expression data and high-sensitivity differential expression analysis. J Proteome Res 18, 732-740. (Abstract)
  23. Tryggvadottir H, Huzell L, Gustbee E, Simonson M, Markkula A, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H (2018) Interactions between ABCB1 genotype and preoperative statin use impact clinical outcomes among breast cancer patients. Front Oncol 8, 428.
  24. Gisterå A, Klement ML, Polyzos KA, Mailer RKW Duhlin A, Karlsson MCI, Ketelhuth DFJ, Hansson GK (2018) Low-density dipoprotein-reactive T cells regulate plasma cholesterol levels and development of atherosclerosis in humanized hypercholesterolemic mice. Circulation 138, 2513-2526. (Abstract)


  1. Quandt D, Zucht HD, Amann A, Wulf-Goldenberg A, Borrebaeck C, Cannarile M, Lambrechts D, Oberacher H, Garrett J, Nayak T, Kazinski M, Massie C, Schwarzenbach H, Maio M, Prins R, Wendik B, Hockett R, Enderle D, Noerholm M, Hendriks H, Zwierzina H, Seliger B (2017) Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget 8, 48507-48520. (Abstract)
  2. Delfani P, Sturfelt G, Gullstrand B, Carlsson A, Kassandra M, Borrebaeck CAK, Bengtsson AA, Wingren C (2017) Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity. Lupus 26, 373-387. (Abstract)
  3. Wästerlid T, Nordström L, Freiburghaus C, Pedersen M, Nørgaard 3, Gang AO, Brown P, Dictor M, Jerkeman M, Ek S (2017) Frequency and clinical implications of SOX11 expression in Burkitt lymphoma. Leuk Lymphoma 58, 1760-1763. (Abstract
  4. Simonsson M, Björner S, Markkula A, Nodin B, Jirström K, Rose C, Borgquist S, Ingvar C, Jernström H (2017) The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size. Int J Cancer 140, 163-175. (Abstract
  5. Levin M, Levander F, Palmason R, Greiff L, Ohlin  M (2017) Antibody-encoding repertoires produced by cells of bone marrow and peripheral blood - a focus on IgE. J Allergy Clin Immunol 139, 1026-1030. (Abstract)
  6. Borrebaeck CAK (2017) Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat Rev Cancer 17, 199-204. (Abstract)
  7. Johansson H, Gradin R, Forreryd A, Agemark M, Zeller K, Johansson A, Larne O, van Vliet E, Borrebaeck C, Lindstedt M (2017) Evaluation of the GARD assay in a blind Cosmetics Europe study. ALTEX 34, 515-523. (Abstract)
  8. Kirik U, Greiff L, Levander F, Ohlin M (2017) Parallel antibody germline gene and haplotype analyses support the validity of immunoglobulin germline gene inference and discovery. Mol Immunol 87, 12-22. (Abstract)
  9. Kirik U, Greiff L, Levander F, Ohlin M (2017) Data on haplotype-supported immunoglobulin germline gene inference. Data Brief 13, 620-640. (Abstract)
  10. Björner S, Rosendahl AH, Simonsson M, Markkula A, Jirström K, Borgquist S, Rose C, Ingvar C, Jernström H (2017) Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups. Oncotarget 8, 9093-9107. (Abstract)
  11. Elebro K, Borgquist S, Rosendahl AH, Markkula A, Simonsson M, Jirström K, Rose C, Ingvar C, Jernström H (2017) High estrogen receptor β expression is prognostic among adjuvant chemotherapy-treated patients - Results from a population-based breast cancer cohort. Clin Cancer Res 23, 766-777. (Abstract)
  12. Liljedahl L, Norlin J, McGuire JN, James P (2017) Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice. Physiol Rep 5, e13187. (Abstract)
  13. Brofelth M, Städe LW, Ekstrand AI, Edfeldt LP, Kovačič R, Nielsen TT, Larsen KL, Duroux L, Wingren C (2017) Site-specific photocoupling of pBpa mutated scFv antibodies for use in affinity proteomics. Biochim Biophys Acta 1865, 985-996. (Abstract)
  14. Malmborg A, Borrebaeck CAK (2017) Testing human skin and respiratory sensitizers. What is good enough? Int J Mol Sci 18, 241. (Abstract)
  15. Sjöholm K, Kilsgård O, Teleman J, Happonen L, Malmström L, Malmström J (2017) Targeted proteomics and absolute protein quantification for the construction of a stoichiometric host-pathogen surface density model. Mol Cell Proteomics 16, S29-S41. (Abstract)
  16. Hjort C, Schiøtz PO, Ohlin M, Würtze PA, Christensen LH, Hoffmann HJ (2017) The number and affinity of productive IgE pairs determine allergen activation of mast cells.  J Allergy Clin Immunol 140, 1167-1170. (Abstract)
  17. Segal-Salto M, Hansson K, Sapir T, Kaplan A, Levy T, Schweizer M, Frotscher M, James P, Reiner O (2017) Proteomics insights into infantile neuronal ceroid lipofuscinosis (CLN1) point to the involvement of cilia pathology in the disease. Hum Mol Genet 26, 1678-1693. (Abstract)
  18. Niksirat H, Andersson L, Golpour A, Chupani L, James P (2017) Quantification of egg proteome changes during fertilization in sterlet Acipenser ruthenus. Biochem Biophys Res Commun 490, 189-193. (Abstract)
  19. Skoog P, Ohlsson M, Fernö M, Rydén L, Borrebaeck CAK, Wingren C (2017) Tumor tissue protein signatures reflect histological grade of breast cancer. PLoS One 12, e0179775. (Abstract)
  20. van Leeuwen-Kerkhoff N, Lundberg K, Westers TM, Kordasti S, Bontkes HJ, de Gruijl TD, Lindstedt M, van de Loosdrecht AA (2017) Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells. J Leukoc Biol 102, 1055-1068. (Abstract)
  21. Vizcaíno JA, Walzer M, Jiménez RC, Bittremieux W, Bouyssié D, Carapito C, Corrales F, Ferro M, Heck AJR, Horvatovich P, Hubalek M, Lane L, Laukens K, Levander F, Lisacek F, Novak P, Palmblad M, Piovesan D, Pühler A, Schwämmle V, Valkenborg D, van Rijswijk M, Vondrasek J, Eisenacher M, Martens L, Kohlbacher O. (2017) A community proposal to integrate proteomics activities in ELIXIR. F1000Res 6, 875. (Abstract)
  22. Teleman J, Hauri S, Malmström J (2017) Improvements in mass ppectrometry assay library generation for targeted proteomics. J Proteome Res 16, 2384-2392. (Abstract)
  23. Hu FJ, Volk AL, Persson H, Säll A, Borrebaeck C, Uhlén M, Rockberg J (2017) Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders. N Biotechnol 45, 80-88. (Abstract)
  24. Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, Montano-Almendras CP, Husby S, Freiburghaus C, Ek S, Pedersen A, Niemann C, Räty R, Brown P, Geisler CH, Andersen MK, Guldberg P, Jerkeman M, Grønbæk K (2017) TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood 130, 1903-1910. (Abstract)
  25. Resjö S, Brus M, Ali A, Meijer HJG, Sandin M, Govers F, Levander F, Grenville-Briggs L, Andreasson E (2017) Proteomic analysis of Phytophthora infestans reveals the importance of cell wall proteins in pathogenicity. Mol Cell Proteomics 16, 1958-1971. (Abstract)
  26. Kirik U, Persson H, Levander F, Greiff L, Ohlin M (2017) Antibody heavy chain variable domains of different germline gene origins diversify through different paths. Front Immunol 8, 1433. (Abstract)
  27. Zeller KS, Forreryd A, Lindberg T, Gradin R, Chawade A, Lindstedt M (2017) The GARD platform for potency assessment of skin sensitizing chemicals. ALTEX 34, 539-559. (Abstract)
  28. Mårtensson A, Abolhalaj M, Lindstedt M, Mårtensson A, Olofsson TC, Vásquez A, Greiff L, Cervin A (2017) Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial. Laryngoscope Investig Otolaryngol 2, 410-416. (Abstract)
  29. Karvonen H, Chiron D, Niininen W, Ek S, Jerkeman M, Moradi E, Nykter M, Heckman CA, Kallioniemi O, Murumägi A, Ungureanu D (2017) Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma. Blood Adv 1, 2257-2268. (Abstract)
  30. Söderström LÅ, Jin H, Caravaca AS, Klement ML, Li Y, Gisterå A, Hedin U, Maegdefessel L, Hansson GK, Olofsson PS (2017) Increased carotid artery lesion inflammation upon treatment with the CD137 agonistic antibody 2A. Circ J 81, 1945-1952. (Abstract)


  1. Kuci V, Nordström L, Conrotto P, Ek S (2016) SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma. Leuk Lymphoma 57, 1883-1892. (Abstract)
  2. Lundberg K, Rydnert F, Broos S, Andersson M, Greiff L, Lindstedt M (2016) Allergen-specific immunotherapy alters the frequency, as well as the FcR and CLR expression profiles of human dendritic cell subsets. PLoS One 11, e0148838. (Abstract)
  3. Chawade A, Alexandersson E, Bengtsson T, Andreasson E, Levander F (2016) Targeted proteomics approach for precision plant breeding. J Proteome Res 15, 638-646. (Abstract)
  4. Thatikonda N, Delfani P, Jansson R, Petersson L, Lindberg D, Wingren C, Hedhammar M (2016) Genetic fusion of single-chain variable fragments to partial spider silk improves target detection in micro- and nanoarrays. Biotechnol J 11, 437–448. (Abstract)
  5. Wingren C (2016) Vart tog den glada, kreativa och innovativa forskaren vägen som vi skulle utbilda? Ledarskap, medarbetarskap och det mänskliga elementet. Lärande i LTH 32, 2-3. (in Swedish) (Paper)
  6. Levin M, King JJ, Glanville J, Jackson KJL, Looney TJ, Hoh RA, Mari A, Andersson M, Greiff L, Fire AZ, Boyd SD, Ohlin M (2016) Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapy. J Allergy Clin Immunol 137, 1535-1544. (Abstract)
  7. Säll A, Persson H, Ohlin M, Borrebaeck CAK, Wingren C (2016) Advancing the Global Proteome Survey platform by using an oriented single chain antibody fragment immobilization approach. New Biotechnol 33, 503-513. (Abstract)
  8. Lindblad O, Cordero E, Puissant A, Macaulay L, Ramos A, Kabir NN, Sun J, Vallon-Christersson J, Haraldsson K, Hemann MT, Borg Å, Levander F, Stegmaier K, Pietras K, Rönnstrand L, Kazi JU (2016) Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML. Oncogene 35, 5119-5131. (Abstract)
  9. Padzik A, Deshpande P, Hollos P, Franker M, Rannikko EH, Cai D, Prus P, Mågård M, Westerlund N, Verhey KJ, James P, Hoogenraad CC, Coffey ET (2016) KIF5C S176 phosphorylation regulates microtubule binding and transport efficiency in mammalian neurons. Front Cell Neurosci 10, 57. (Abstract)
  10. Mårtensson A, Greiff L, Lamei SS, Lindstedt M, Olofsson TC, Vasquez A, Cervin A (2016) Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers. Int Forum Allergy Rhinol 6, 956-963. (Abstract)
  11. Simonsson M, Veerla S, Markkula A, Rose C, Ingvar C, Jernström H (2016) CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients. BMC Cancer 16, 256. (Abstract)
  12. Teleman J, Chawade A, Sandin M, Levander F, Malmström J (2016) Dinosaur: a refined open source peptide MS feature detector. J Proteome Res 15, 2143-2151. (Abstract
  13. Gray AC, Sidhu SS, Chandrasekera PC, Hendriksen CFM, Borrebaeck CAK (2016) Animal friendly Affinity reagents – replacing the needless in the haystack. TIBTECH 34, 960-969. (Abstract)
  14. Delfani P, Dexlin Mellby L, Nordström M, Holmér A, Ohlsson M, Borrebaeck CAK, Wingren C (2016) Technical advances of the recombinant antibody microarray technology platform for clinical immunoproteomics. PLoS One 11, e0159138. (Abstract)
  15. Säll A, Walle M, Wingren C, Müller S, Nyman T, Vala A, Ohlin M, Borrebaeck CAK, Persson H (2016) Generation and analyses of human synthetic antibody libraries and their application for protein microarrays. Prot Eng Des Select 29, 427-437. (Abstract)
  16. Emruli VK, Olsson R, Ek F, Ek S (2016) Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma. BMC Cancer 16, 493. (Abstract)
  17. Waldemarson S, Kurbasic E, Krogh M, Cifani P, Berggård T, Borg Å, James P (2016) Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples. Breast Cancer Res 18, 69. (Abstract)
  18. Lundberg K, Rydnert F, Broos S, Andersson M, Greiff L, Lindstedt M (2016) C-type lectin receptor expression on human basophils and effects of allergen-specific immunotherapy. Scand J Immunol 84, 150-157. (Abstract)
  19. Gray AC, Sidhu SS, Chandrasekera PC, Hendriksen CF, Borrebaeck CAK (2016) Animal-based antibodies: Obsolete. Science 353, 452-453. (Abstract)
  20. Sandström Gerdtsson , Wingren C, Persson H, Delfani P, Malin Nordström M, Ren H, Wen X, Ringdahl U, Borrebaeck CAK, Hao J (2016) Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis. Mol Oncol 10, 1305-1316. (Abstract)
  21. Gerdtsson AS, Dexlin-Mellby L, Delfani P, Berglund E, Borrebaeck CAK, Wingren C (2016) Evaluation of solid supports for slide- and well-based recombinant antibody microarrays. Microarrays 5, 16. (Abstract)
  22. Forreryd A, Zeller KS, Lindberg T, Johansson H, Lindstedt M (2016) From genome-wide arrays to tailor-made biomarker readout – Progress towards routine analysis of skin sensitizing chemicals with GARD. Toxicol In Vitro 37 178-188. (Abstract)
  23. Stella R, Barrucci F, Angeletti R, James P, Montesissa C, Biancotto G (2016) Targeted proteomics for the indirect detection of dexamethasone treatment in bovines. Anal Bioanal Chem 408, 8343-8353. (Abstract)
  24. Liljedahl L, Pedersen, MH, Norlin J, McGuire JN, James P (2016) N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models. Clin Proteomics 13, 22. (Abstract)
  25. Kilsgård O, Karlsson C, Malmström E, Malmström J (2016) Differential compartmentalization of Streptococcus pyogenes virulence factors and host protein binding properties as a mechanism for host adaptation. Int J Med Microbiol 306, 504-516. (Abstract
  26. Pauly F, Fjordén K, Leppä S, Holte H, Björkholm M, Fluge Ø, Møller Pedersen L, Eriksson M, Isinger-Ekstrand A, Borrebaeck CAK, Jerkeman M, Wingren C (2016) Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study. Blood Cancer J 6, e501. (Abstract)
  27. Melin Fürst C, Åhrman E, Bratteby K, Waldemarson S, Malmström J, Blom AM (2016) Quantitative mass spectrometry to study inflammatory cartilage degradation and resulting interactions with the complement system. J Immunol 197, 3415-3424. (Abstract)
  28. Masoumi KC, Daams R, Sime W, Siino V, Ke H, Levander F, Massoumi R (2016) NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling. Mol Biol Cell mbc.E16-07-0547. (Abstract)
  29. Ellmark P, Mangsbo SM, Lindstedt M (2016) Selective FcγR engagement by human agonistic anti-CD40 antibodies. Transl Cancer Res 5, S839-841. (Abstract)
  30. Mellby LD, Holmer A, Wingren C, Johansen J, Bojesen SE, Nordestgaards BG, Borrebaeck CAK (2016) Early-stage diagnosis of pancreatic cancer offers opportunity to improve overall patient survival. Ann Oncol 27, 6. (Abstract)
  31. Persson M, Simonsson M, Markkula A, Rose C, Ingvar C, Jernström H (2016) Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort. Br J Cancer 115, 382-390. (Abstract)
  32. Wingren C (2016) Antibody-based proteomics. Adv Exp Med Biol 926 163-179. (Abstract)


    1. Teleman J, Röst H, Rosenberger G, Schmitt U, Malmström L, Malmström J, Levander F (2015) DIANA - algorithmic improvements for analysis of data-independent acquisition MS data. Bioinformatics 31,555-562. (Abstract)
    2. Reisinger K, Hoffmann S, Alépée N, Ashikaga T, Barroso J, Elcombe C, Gellatly N, Galbiati V, Gibbs S, Groux H, Hibatallah J, Keller D, Kern P, Klaric M, Kolle S, Kuehnl J, Lambrechts N, Lindstedt M, Millet M, Martinozzi-Teissier S, Natsch A, Petersohn D, Pike I, Sakaguchi H, Schepky A, Tailhardat M, Templier M, van Vliet E, Maxwell G (2015) Systematic evaluation of non-animal test methods for skin sensitisation safety assessment. Toxicol In Vitro 29, 259-270. (Abstract)
    3. Hosseini S, Resjö S, Liu Y, Durling M, Heyman F, Levander F, Liu Y, Elfstrand M, Funck Jensen D, Andreasson E, Karlsson M (2015) Comparative proteomic analysis of hyphae and germinating cysts of Phytophthora pisi and Phytophthora sojaeJ Proteomics 117,  24–40. (Abstract)
    4. Bradbury ARM, Plückthun A, Anderson S, Arap W, Baralle FE, Beck A, Begley  CG, Benet LZ, Benhar I, Blackshaw S , Blow N, Boeke J, Borrebaeck CAK, Burrone OR, Burton DR , Campbell E, Carter P, Cattaneo A, Cesareni G, Chakraborti S, Chalmers AD, Chaput JC, Chasteen L, Chester KA, Christ D, Clark M, Close D, D'Angelo S, Dimitrov DS, Dübel S, Edwards A, Ellington A, Magee M, Marasco W, Marks JD, Mathias SL, McCafferty J, Montelione GT, Neri D, Nishimura SI, Not T, Oprea T, Pai JK, Parren P, Pasqualini R, Pavlik P, Qiu J, Quarmby V, Reichert JM, Rimm D, Santoro C, Sblattero D, Schirrmann T, Scott J, Sechi S, Sidhu S, Siegel R, Sitia R, Skerra A, Soh HT, Doo Song BD, Song P, Staquicini FI, Stoevesandt O, Taussig  MJ, Feldhaus M, Ferrara F, Freeman NL, Fuh G, Gaiotto  T, Gatlin CL, Georgiou G, Glanville J, Gold L, Gräslund S, Griffiths AD, Haab B, Hoheisel JD, Hornsby M, Hudson P, Hust  M, Huston JS, Kay B, Kim  KM, Kiss C, Koide S, Kossiakoff  A, LaBaer J, Landegren U, Lane D, Larrick J, Lee S, Lefranc MP, Liu B, Lou JL, Lund-Johansen F, Macor P, Tawfik DS, Trimmer JS, Uhlén M, Velappan N, Waldmann H, Waldo GS, Ward S, Weiner  M, Wells J, Wittrup D, Wu A, Wu H, Yoo JS, Zhou Y (2015) Standardize antibodies used in research. Nature 518, 27-29. (Full text)
    5. Ko BK, Lee SY, Lee YH, Hwang IS, Persson H, Rockberg J, Borrebaeck C, Park D, Kim KT, Uhlén M, Lee JS (2015) Combination of novel HER2 targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2 positive gastric cancer. Mol Oncol 9, 398-408. (Abstract)
    6. Chawade A, Sandin M, Teleman J, Malmström J, Levander F (2014) Data processing has major impact on the outcome of quantitative label-free LC-MS analysis. J Proteome Res 14, 676-687. (Abstract)
    7. Ohlin M, Söderberg-Nauclér C (2015) Human antibody technology and the development of antibodies against cytomegalovirus. Mol Immunol 67, 153-170. (Abstract)
    8. Husby S, Ralfkiaer U, Garde C, Zandi R, Ek S, Kolstad A, Jerkeman M, Laurell A, Räty R, Pedersen LB, Pedersen A, Ehinger M, Sundström C, Karjalainen-Lindsberg ML, Delabie J, Clasen-Linde E, Brown P, Cowland J, Workman CT, Geisler CH, Grønbæk K (2015) miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator. Blood 125, 2669-2677. (Abstract)
    9. Forreryd A, Johansson H, Albrekt AS, Borrebaeck CAK, Lindstedt M (2015) Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature. PLoS One 10, e0118808. (Abstract)
    10. Stella R, Biancotto G, Arrigoni G, Barrucci F, Angeletti R, James P (2015) Proteomics for the detection of indirect markers of steroids treatment in bovine muscle. Proteomics 15, 2332–2341. (Abstract)
    11. Nordström L, Andersson E, Kuci V, Gustavsson E, Holm K, Ringnér M, Guldberg P, Ek S (2015) DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells. BMC Cancer 15, 273. (Abstract)
    12. Kuci V, Nordström L, Jerkeman M, Ek S (2015) Emerging role of SOX11 in mantle cell lymphoma. Blood Lymphat Cancer 5, 35-42. (Abstract)
    13. Niksirat H, James P, Andersson L, Kouba A, Kozák P (2015) Label-free protein quantification in freshly ejaculated versus post-mating spermatophores of the noble crayfish Astacus astacus. J Proteomics 123, 70–77. (Abstract)
    14. Qi D, Lawless C, Teleman J, Levander F, Holman SW, Hubbard S, Jones A (2015) The representation of selected-reaction monitoring data in the mzQuantML data standard. Proteomics 15, 2592–2596. (Abstract)
    15. Levin M, Otten H, von Wachenfeldt C, Ohlin M (2015) A folded and immunogenic IgE-hyporeactive variant of the major allergen Phl p 1 produced in Escherichia coli. BMC Biotechnol 15, 52. (Abstract)
    16. Sandin M, Chawade A, Levander F (2015) Is label-free LC-MS/MS ready for biomarker discovery? Proteomics Clin Appl 9, 289-294. (Abstract)
    17. Franchin C, Cesaro L, Salvi M, Millioni R, Iori E, Cifani P, James P, Arrigoni G, Pinna L (2015) Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. Biochim Biophys Acta 1854, 609–623. (Abstract)
    18. Kurbasic E, Sjöström M, Krogh M, Folkesson E, Grabau D, Hansson K, Rydén L, Waldemarson S, James P, Niméus E (2015) Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases. Clin Proteomics 12, 13. (Abstract)
    19. Ohlin M, von Schantz L, Schrader TE, Ostermann A, Logan D, Fisher SZ (2015) Crystallization, neutron data collection, initial structure refinement and analysis of a xyloglucan heptamer bound to an engineered carbohydrate binding module from xylanase. Acta Cryst F 71, 1072-1077. (Abstract)
    20. Cifani P, Kirik U, Waldemarson S, James P (2015) Molecular portrait of breast cancer derived cell lines reveals poor similarity with tumors. J Proteome Res 14, 2819–2827. (Abstract)
    21. Godzwon M, Säll A, Levin M, Ohlin M (2015) A microarray-based reaction rate analysis platform. Is there evidence of validity? J Immunol Methods 426, 144-146. (Abstract)
    22. Paës G, von Schantz L, Ohlin M (2015) Bioinspired assemblies of plant cell wall polymers unravel affinity properties of carbohydrate-binding modules. Soft Matter 11, 6586-6594. (Abstract)
    23. Ellmark P, Mangsbo SM, Furebring C, Tötterman TH, Norlén P (2015)  Kick-starting the cancer-immunity cycle by targeting CD40. OncoImmunology 4, e1011484. (Abstract)
    24. Lindlöf A, Aakash C, Sikora P, Olsson O (2015) Comparative transcriptomics of Sijung and Jumli marshi rice during early chilling stress imply multiple protective mechanisms. PloS One 10, e0125385. (Abstract)
    25. Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H (2015) Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients. BMC Clin Pathol 15:8. (Abstract)
    26. Elebro K, Borgquist S, Simonsson M, Markkula M, Jirström K, Ingvar C, Rose C, Jernström H (2015) Combined androgen and estrogen receptor status in breast cancer: Treatment prediction and prognosis in a population-based prospective cohort. Clin Cancer Res 21, 3640-3650. (Abstract)
    27. Rosendahl AH, Perks CM, Zeng L, Markkula M, Simonsson M, Rose C, Ingvar C, Holly JMP, Jernström H (2015) Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer. Clin Cancer Res 21, 1877-1887. (Abstract)
    28. Olsson E, Winter C, George A, Chen Y, Howlin J, Tang MH, Dahlgren M, Schulz R, Grabau D, van Westen D, Fernö M, Ingvar C, Rose C, Bendahl PO, Rydén L, Borg Å, Gruvberger-Saal SK, Jernström H, Saal LH (2015) Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol Med 7, 1034-1047. (Abstract)
    29. Städe LW, Nielsen TT, Duroux L, Hinge M, Shimizu K, Gurevich L, Kristensen PK, Wingren C, Larsen KL (2015) Nonfouling tunable beta CD dextran polymer films for protein applications. ACS Appl Mater Interfaces 7, 4160-4168. (Abstract)
    30. Lindblad O, Li T, Su X, Sun J, Kabir NN, Levander F, Zhao H, Lu G, Rönnstrand L, Kazi JU (2015) BEX1 acts as a tumor suppressor in acute myeloid leukemia. Oncotarget 6, 21395-21405. (Abstract)
    31. Fisher Z, von Schantz L, Håkansson M, Logan DT, Ohlin M (2015) Neutron crystallographic studies reveal hydrogen bond and water mediated interactions between a carbohydrate-binding module and its bound carbohydrate ligand. Biochemistry 54, 6435–6438. (Abstract)
    32. Säll A, Sjöholm K, Waldemarson S, Happonen L, Karlsson C, Persson H, Malmström J (2015) Development of phage-based antibody fragment reagents for affinity enrichment of bacterial IgG binding proteins. J Proteome Res 14,4704-4713. (Abstract)
    33. Gerdtsson AS, Malats N, Säll A, Real FX, Porta M, Skoog P, Persson H, Wingren C, Borrebaeck CAK (2015) A multicenter trial defining a serum protein signature associated with pancreatic ductal adenocarcinoma. Int J Proteomics 2015, 587250. (Abstract)
    34. Raison C, Borrebaeck C (2015) Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck. Expert Rev Mol Diagn 14, 1-2. (Abstract)


    1. Levin M, Davies AM, Liljekvist M, Carlsson F, Gould HJ, Sutton BJ, Ohlin M (2014) Human IgE against the major allergen Bet v 1 – defining an epitope with limited cross-reactivity between different PR-10 family proteins. Clin Exp Allergy 44, 288-299. (Abstract)
    2. Gadermaier E, Levin M, Flicker S, Ohlin M (2014) The human IgE repertoire. Int Arch Allergy Immunol 163, 77-91. (Abstract)
    3. Hazarika P, Behrendt JM, Petersson L, Wingren C, Turner ML (2014) Photopatterning of self assembled monolayers on oxide surfaces for the selective attachment of biomolecules. Biosens Bioelectron 53C, 82-89. (Abstract)
    4. Borrebaeck CA, Sturfelt G, Wingren C (2014) Recombinant antibody microarray for profiling the serum proteome of SLE. Methods Mol Biol 1134, 67-78. (Abstract)
    5. Ohlin M (2014) Utveckling av forskarutbildningskurser. Från enskilt läsande mot ett problembaserat lärande. Lärande i LTH 24, 4-5. (in Swedish) (full text)
    6. Sherwood V, Chaurasiya SK, Ekström EJ, Guilmain W, Liu Q, Koeck T, Brown K, Hansson K, Agnarsdóttir M, Bergqvist M, Jirström K, Ponten F, James P, Andersson T (2014) WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis 35, 784-794. (Abstract)
    7. Lundberg K, Rydnert F, Greiff L, Lindstedt M (2014) Human blood dendritic cell subsets exhibit discriminative pattern recognition receptor profiles. Immunology 142, 279–288. (Abstract
    8. Albrekt AS, Johansson H, Börje A, Borrebaeck CAK, Lindstedt M (2014) Differentially regulated pathways in MUTZ-3 cells stimulated with skin sensitizers. BMC Pharmacol Toxicol 15, 5. (Abstract)
    9. Johansson H, Lindstedt M (2014) Prediction of skin sensitizers using alternative methods to animal experimentation. Basic Clin Pharmacol Toxicol 115, 110-117. (Abstract)
    10. Borrebaeck CA, Wingren C (2014) Antibody array generation and use. Methods Mol Biol 1131, 563-571. (Abstract)
    11. Rydnert F, Lundberg K, Greiff L, Lindstedt M (2014) Circulating CD1c+ DCs are superior at activating Th2 responses upon Phl p stimulation compared to basophils and pDCs. Immunol Cell Biol 92, 557–560. (Abstract)
    12. Johansson H, Rydnert F, Kuhnl J, Schepky A, Borrebaeck CAK, Lindstedt M (2014) GARD in-house validation – A proof of concept. Toxicol Sci 139, 362-370. (Abstract)
    13. Sjöholm K, Karlsson C, Linder A, Malmström J (2014) A comprehensive analysis of the Streptococcus pyogenes and human plasma protein interaction network. Mol Biosyst 10, 1698-1708. (Abstract)
    14. Resjö S, Ali A, Meijer HJ, Seidl MF, Snel B, Sandin M, Levander F, Govers F, Andreasson E (2014) Quantitative label-free phosphoproteomics of six different life stages of the late blight pathogen Phytophthora infestans reveals abundant phosphorylation of members of the CRN effector family. J Proteome Res 13, 1848-1859. (Abstract)
    15. Ohlin M (2014) A new look at a poorly immunogenic neutralization epitope on cytomegalovirus glycoprotein B. Is there cause for antigen redesign? Mol Immunol 60, 95-102. (Abstract)
    16. Teleman J, Dowsey AW, Gonzalez-Galarza FF, Perkins S, Pratt B, Rost H, Malmström L, Malmström J, Jones AR, Deutsch EW, Levander F (2014) Numerical compression schemes for proteomics mass spectrometry data. Mol Cell Proteomics 13, 1537-1542. (Abstract)
    17. Petersson L, Coen M, Amro NA, Truedsson L, Borrebaeck CAK, Wingren C (2014) Miniaturization of multiplexed planar recombinant antibody arrays for serum protein profiling. Bioanalysis 6, 1175-1185. (Abstract)
    18. Petersson L, Dexlin Mellby L, Bengtsson AA, Sturfelt G, Borrebaeck CAK, Wingren C (2014) Multiplexing of miniaturized planar antibody arrays for serum protein profiling – Biomarker discovery in SLE nephritis. Lab Chip 14, 1931-1942. (Abstract)
    19. Nordström L, Sernbo S, Eden P, Grønbaek K, Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundström C, Laurell A, Delabie J, Ehinger M, Jerkeman M, Ek S (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study. Br J Haematol 166, 98-108. (Abstract)
    20. Röst HL, Rosenberger G, Navarro P, Gillet L, Miladinovic SM, Schubert OT, Wolskit W, Collins BC, Malmström J, Malmström L, Aebersold R (2014) OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat Biotechnol 32, 219-223. (Abstract)
    21. Pauly F, Smedby KE, Jerkeman M, Hjalgrim H, Ohlsson M, Rosenquist R, Borrebaeck CAK, Wingren C (2014) Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays. Leukemia Res 38, 682-690. (Abstract)
    22. Bengtsson T, Weighill D, Proux-Wéra E, Levander F, Resjö S, Burra DD, Moushib LI, Hedley PE, Liljeroth E, Jacobson D, Alexandersson E, Andreasson E (2014) Proteomics and transcriptomics of the BABA-induced resistance response in potato using a novel functional annotation approach. BMC Genomics 15, 315. (Abstract)
    23. Girardi C, James P, Zanin S, Pinna LA, Ruzzene M (2014) Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions. Biochim Biophys Acta 1843, 1865–1874 (Abstract)
    24. Chawade A, Alexandersson E, Levander F (2014) Normalyzer: A tool for rapid evaluation of normalization methods for Omics data sets. J Proteome Res 13, 3114-3120. (Abstract)
    25. Stella R, Arrigoni G, Biancotto G, Krogh M, Vascellari M, Lega F, Pozza G, Angeletti R, Andrighetto I, James P (2014) Confirmation of protein biomarkers of corticosteroids treatment in veal calves sampled under field conditions. J Proteome Res 13, 1794–1799. (Abstract)
    26. Evans-Axelsson S, Vilhelmsson Timmermand O, Welinder C, Borrebaeck CAK, Strand SE, Tran TA, Jansson B, Bjartell A (2014) Preclinical evaluation of 111In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer. Am J Nucl Med Mol Imaging 4, 311-323. (Abstract)
    27. Forreryd A, Johansson H, Albrekt AS, Lindstedt M (2014) Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitization. BMC Genomics 15, 379. (Abstract)
    28. Ali A, Alexandersson E, Sandin M, Resjö S, Lenman M, Hedley P, Levander F, Andreasson E (2014) Quantitative proteomics and transcriptomics of potato in response to Phytophthora infestans in compatible and incompatible interactions. BMC Genomics 15, 497. (Abstract)
    29. Petersson L, Duroure NB, Auger A, Dexlin-Mellby L, Borrebaeck CAK, Ikhlef AA, Wingren C (2014) Generation of miniaturized planar recombinant antibody arrays using a microcantilever-based printer. Nanotechnology 25, 275104 (Abstract)
    30. Kirik U, Hansson K, Krogh M, Jonsson M, Nilbert M, James P, Carneiro A (2014) Discovery-based protein expression profiling identifies distinct subgroups and pathways in Leiomyosarcomas. Mol Cancer Res 12, 1729-1739. (Abstract)
    31. Levin M, Rotthus S, Wendel S, Najafi N, Källström E, Focke-Tejkl M, Valenta R, Flicker S, Ohlin M (2014) Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5. Clin Exp Allergy 44, 1409-1419. (Abstract)
    32. Petersson L, Städe LW, Brofelth M, Gärtner S, Fors E, Sandgren M, Vallkil J, Olsson N, Larsen KL, Borrebaeck CA, Duroux L, Wingren C (2014) Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid support. Biochim Biophys Acta 1844, 2164-2173. (Abstract)
    33. Niksirat H, Andersson L, James P, Kouba A, Kozák P (2014) Proteomic profiling of the signal crayfish Pacifastacus leniusculus egg and spermatophore. Anim Reprod Sci 149, 335-344. (Abstract)
    34. Nordström M, Wingren C, Rose C, Bjartell A, Becker C, Lilja H, Borrebaeck CAK (2014) Identification of plasma protein profiles associated with risk groups of prostate cancer patients. Proteomics Clin Appl 8, 951-962. (Abstract)
    35. Nilsson JS, Broos S, Akagi T, Akashi M, Hermansson A, Cayé-Thomasen P, Lindstedt M, Greiff L (2014) Amphiphilic γ-PGA nanoparticles administered on rat middle ear mucosa produce adjuvant-like immunostimulation in vivo. Acta Otolaryngol 134, 1034-1041. (Abstract)
    36. von Schantz L, Håkansson M, Logan DT, Nordberg-Karlsson E, Ohlin M (2014) Polar interactions with branching xyloses and CH-π interactions define carbohydrate binding module recognition of xyloglucan. Proteins 82, 3466-3475. (Abstract)
    37. Burra D, Berkowitz O, Hedley PE, Morris J, Resjö S, Levander F, Liljeroth E, Andreasson E, Alexandersson E (2014) Phosphite-induced changes of the transcriptome and secretome in Solanum tuberosum leading to resistance against Phytophthora infestans. BMC Plant Biol 14, 254. (Abstract)
    38. Mangsbo SM, Broos S, Fletcher E, Veitonmäki N, Furebring C, Dahlén E, Norlén P, Lindstedt M, Tötterman TH, Ellmark P (2014) The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity. Clin Cancer Res 21,1115-1126. (Abstract)
    39. Komulainen E, Zdrojewska J, Freemantle E, Mohammad H, Kulesskaya N, Deshpande P, Marchisella F, Mysore R, Hollos P, Michelsen KA, Mågard M, Rauvala H, James P, Coffey ET (2014) JNK1 controls dendritic field size in L2/3 and L5 of the motor cortex, constrains soma size, and influences fine motor coordination. Front Cell Neurosci 8, 272. (Abstract)
    40. Säll A, Carlsson F, Olsson N, Wingren C, Ohlin M, Persson H, Waldemarson S (2014) AFFIRM – a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis. J Proteome Res 13, 5837-5847. (Abstract)
    41. Zeller K (2014) Undersökning av inlärningsstilar i samband med problembaserat lärande. Lärande i LTH 27, 4-6. (in Swedish)
    42. Galli J, Oelrich J, Taussig MJ, Andréasson U, Ortega-Paino E, Landegren U (2014) The Biobanking Analysis Resource Catalogue (BARCdb): a new research tool for the analysis of biobank samples. Nucleic Acids Res 43, D1158-D1162. (Abstract)
    43. Hulteberg C, Axelsson J, Bauer F, Waldemarson S (2014) Frågeställningar i examensarbeten. In: Proceedings of the LTH 8th Pedagogic Inspirational Conference. (in Swedish)
    44. von Schantz L, Schagerlöf H, Nordberg-Karlsson E, Ohlin M (2014) Characterization of the substitution pattern of cellulose derivatives using carbohydrate-binding modules. BMC Biotechnol 14, 113. (Abstract)
    45. Sandin LC, Eriksson F, Ellmark P, Loskog AS, Tötterman TH, Mangsbo SM (2014) Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo. Oncoimmunology 3, e27614 (Abstract)
    46. Sandin LC, Orlova A, Gustafsson E, Ellmark P, Tolmachev V, Tötterman TH, Mangsbo SM (2014)Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer. Cancer Immunol Res 2, 80-90. (Abstract)
    47. Simonsson M, Markkula A, Bendahl PO, Rose C, Ingvar C, Jernström H (2014)Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events. Springerplus 3:261. (Abstract)


    1. Sernbo S, Borrebaeck CAK, Uhlén M, Jirström K, Ek S (2013) Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro. PLoS One 8, e70596. (Abstract)
    2. Levin M, Rydnert F, Källström E, Tan LW, Wormald PJ, Lindstedt M, Greiff L, Ohlin M (2013) Phl p 1–specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment. J Immunol 191, 551-560. (Abstract) (self-archived copy)
    3. Johansson H, Albrekt AS, Borrebaeck CAK, Lindstedt M (2013) The GARD assay for assessment of chemical skin sensitizers. Toxicol In Vitro 27, 1163-1169. (Abstract)
    4. Ghatnekar O, Andersson R, Svensson M, Persson U, Ringdahl U, Zeilon P, Borrebaeck CAK (2013) Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int J Cancer 133, 2392-2397. (Abstract)
    5. Oosterhoff D, Heusinkveld M, Lougheed SM, Kosten I, Lindstedt M, Bruijns SC, van Es T, van Kooyk Y, van der Burg SH, de Gruijl TD (2013) Intradermal delivery of TLR agonists in a human explant skin model: Preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans. J Immunol 190, 3338-3345. (Abstract)
    6. Lundberg K, Albrekt AS, Nelissen I, Santegoets S, de Gruijl TD, Gibbs S, Lindstedt M (2013) Transcriptional profiling of human dendritic cell populations and models - Unique profiles of in vitro dendritic cells and implications on functionality and applicability. PLoS One 8, e52875. (Abstract)
    7. Levin M, Ohlin M (2013) Inconclusive evidence for or against positive antigen selection in the shaping of human IgE repertoires - a call for new approaches. Int Arch Allergy Immunol 161, 122-126. (Abstract)
    8. Brodin E, Ohlin M, Lindén J (2013) Mentorship, supervision and learning experience in PhD education. Stud High Educ 38, 639-662. (Abstract)
    9. Teleman J, Waldemarson S, Malmström J, Levander F (2013) Automated quality control system for LC-SRM setups. J Proteomics 95, 77-83. (Abstract)
    10. Sandin M, Teleman J, Malmström J, Levander F (2013) Data processing methods and quality control strategies for label-free LC-MS protein quantification. Biochim Biophys Acta 1844, 29-41. (Abstract)
    11. Mayer G, Montecchi-Palazzi L, Ovelleiro D, Jones AR, Binz PA, Deutsch EW, Chambers M, Kallhardt M, Levander F, Shofstahl J, Orchard S, Antonio Vizcaíno J, Hermjakob H, Stephan C, Meyer HE, Eisenacher M, HUPO-PSI Group (2013)The HUPO proteomics standards initiative- mass spectrometry controlled vocabulary. Database 2013, bat009. (Abstract)
    12. Sandin M, Ali A, Hansson K, Månsson O, Andreasson E, Resjö S, Levander F (2013) An adaptive alignment algorithm for quality-controlled label-free LC-MS. Mol Cell Proteomics 12, 1407-1420. (Abstract)
    13. Fernandez C, Sandin M, Sampaio JL, Almgren P, Narkiewicz K, Hoffmann M, Hedner T, Wahlstrand B, Simons K, Shevchenko A, James P, Melander O (2013) Plasma lipid composition and risk of developing cardiovascular disease. PLoS One 8, e71846. (Abstract)
    14. Oehmcke S, Westman J, Malmström J, Mörgelin M, Olin AI, Kreikemeyer B, Herwald H (2013) A novel role for pro-coagulant microvesicles in the early host defense against Streptococcus pyogenes. PLoS Pathog 9, e1003529. (Abstract)
    15. Andersson KM, Meerupati T, Levander F, Friman E, Ahrén D, Tunlid A (2013) Proteome of the nematode-trapping cells of the fungus Monacrosporium haptotylum. Appl Environ Microbiol 79, 4993-5004. (Abstract)
    16. Olsson N, Carlsson P, James P, Hansson K, Waldemarson S, Malmström P, Fernö M, Ryden L, Wingren C, Borrebaeck CAK (2013) Grading breast cancer tissues using molecular portraits. Mol Cell Proteomics 12, 3612-3623. (Abstract)
    17. Pauly F, Dexlin-Mellby L, Ek S, Ohlin M, Olsson N, Jirström K, Dictor M, Schoenmakers S, Borrebaeck CAK, Wingren C (2013) Protein expression profiling of formalin-fixed paraffin-embedded tissue using recombinant antibody microarrays. J Proteome Res 12, 5943–5953. (Abstract)
    18. Wingren C (2013) Novel type of protein chip for multiplex detection of autoantibodies. Expert Rev Proteomics 10, 417-420. (Abstract)
    19. Butler E, Alsterfjord M, Olofsson TC, Karlsson C, Malmström J, Vásquez A (2013) Proteins of novel lactic acid bacteria from Apis mellifera mellifera: an insight into the production of known extra-cellular proteins during microbial stress. BMC Microbiol 13, 235. (Abstract)


    1. Olsson N, Wallin S, James P, Borrebaeck CAK, Wingren C (2012) Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties. Protein Sci 21, 1897–1910. (Abstract)
    2. Pedersen HL, Fangel JU, McCleary B, Ruzanski C, Rydahl MG, Ralet M-C, Farkas V, von Schantz L, Marcos SE, Andersen MCF, Field R, Ohlin M, Knox JP, Clausen MH, Willats WGT (2012) Versatile high-resolution oligosaccharide microarrays for plant glycobiology and cell wall research. J Biol Chem 287, 39429-39438. (Abstract)

    3. Sandström A, Andersson R, Segersvärd R, Löhr M, Borrebaeck CAK, Wingren C (2012) Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures. Proteomics Clin Appl 6, 486-496. (Abstract)
    4. Nordström L, Andréasson U, Jerkeman M, Dictor M, Borrebaeck C, Ek S (2012) Expanded clinical and experimental use of SOX11 - using a monoclonal antibody. BMC Cancer 12, 269. (Abstract)
    5. Hertwig F, Meyer K, Braun S, Ek S, Spang R, Pfenninger CV, Artner I, Prost G, Chen X, Biegel JA, Judkins AR, Englund E, Nuber UA (2012) Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells. Cancer Res 72, 3381-3392. (Abstract)
    6. Borrebaeck CAK (2012) Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information? Proteomics Clin Appl 6, 343-345. (Abstract)
    7. Olsson N, James P, Borrebaeck CAK, Wingren C (2012) Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry. Mol Cell Proteomics 11, 342-354. (Abstract)
    8. Broos S,  Sandin LC, Apel J, Tötterman TH, Akagi T, Akashi M,Borrebaeck CAK, Ellmark P, Lindstedt M (2012) Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles. Biomaterials 33, 6230-6239. (Abstract)
    9. Kirik U, Cifani P, Albrekt AS, Lindstedt M, Heyden A, Levander F (2012) Multi-model pathway enrichment methods for functional evaluation of expression regulation. J Proteome Res 11, 2955-2967. (Abstract)
    10. von Schantz L, Håkansson M, Logan DT, Walse B, Österlin J, Nordberg-Karlsson E, Ohlin M (2012) Structural basis for carbohydrate binding specificity - a comparative assessment of two engineered carbohydrate binding modules. Glycobiology 22, 948-961. (Abstract) (PDB: 2Y6J, 2Y6K, 2Y6L, 2Y6H, 2Y64, 2Y6G)
    11. Wingren C, Sandström A, Segersvärd R, Carlsson A, Andersson R, Löhr M, Borrebaeck CAK (2012) Identification of serum biomarker signatures associated with pancreatic cancer. Cancer Res 72, 2481-2490. (Abstract)
    12. Carlsson F, Trilling M, Perez F, Ohlin M (2012) A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus. J Immunol Methods 376, 69-78. (Abstract)
    13. Kristensson M, Olsson K, Carlson J, Wullt B, Sturfelt G, Borrebaeck CAK, Wingren C (2012) Design of recombinant antibody microarrays for urinary proteomics. Proteomics Clin App 6, 291-296. (Abstract)
    14. Larsson S, Resjö S, James P, Holm C (2012) Characterization of the lipid droplet proteome of a clonal insulin-producing β-cell line (INS-1 832/13). J Proteome Res 11, 1264-1273.
    15. Stella R, Cifani P, Peggion C, Hansson K, Lazzari C, Bendz M, Levander F, Sorgato M-C, Bertoli A, James P  (2012) Relative quantification of membrane proteins in wild-type and PrP-knockout cerebellar granule neurons. J Proteome Res 11, 523-536.
    16. Antberg L, Cifani P, Sandin M, Levander F, James P (2012) A critical comparison of multidimensional separation methods for increasing protein expression coverage. J Proteome Res 11, 2644-2652.
    17. Björkblom B, Padzik A, Mohammad H, Westerlund N, Komularinen E, Hollos P, Parviainen L, Papageorgiou A, Iljin K, Kallionemi O, Kallajoki M, Courtney MJ, Mågård M, James P, Coffey ET (2012) c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells. Mol Cell Biol 32, 3513-3526. (Abstract)
    18. Malmström J, Karlsson C, Nordenfelt P, Ossola R, Weisser H, Quandt A, Hansson K, Aebersold R, Malmström L, Björck L (2012) Streptococcus pyogenes in Human Plasma: Adaptive mechanisms analyzed by mass-spectrometry-based proteomics. J Biol Chem 287, 1415-1425.
    19. Eliasson M, Olin AI, Malmström JA, Mörgelin M, Bodelsson M, Collin M, Egesten A (2012) Characterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells. J Interferon Cytokine Res 32, 524-533. (Abstract)
    20. Teleman J, Karlsson C, Waldemarson S, Hansson K, James P, Malmström J, Levander F (2012) Automated selected reaction monitoring software for accurate label-free protein quantification. J Proteome Res 11, 3766-3773.
    21. Hallgren O, Malmström J, Malmström L, Andersson-Sjöland A, Wildt M, Tufvesson E, Juhasz P, Marko-Varga G, Westergren-Thorsson G (2012) Splicosomal and serine and arginine-rich splicing factors as targets for TGF-beta. Fibrogenesis Tissue Repair 5, 6.
    22. Waldemarson S, Krogh M, Alaiya A, Kirik U, Schedvins K, Auer G, Hansson KM, Ossola R, Aebersold R, Lee H, Malmström J, James P (2012) Protein expression changes in ovarian cancer during the transition from benign to malignant. J Proteome Res 11, 2876-2689.
    23. Malmström L, Malmström J, Selevsek N, Rosenberger G, Aebersold R (2012) Automated workflow for large-scale selected reaction monitoring experiments. J Proteome Res 11, 1644-1653.
    24. Carlsson MC, Balog CI, Kilsgård O, Hellmark T, Bakoush O, Segelmark M, Fernö M, Olsson H, Malmström J, Wuhrer M, Leffler H (2012) Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease. Biochim Biophys Acta 1820, 1366-1372.
    25. Cederfur C, Malmström J, Nihlberg K, Block M, Breimer ME, Bjermer L, Westergren-Thorsson G, Leffler H. Glycoproteomic identification of galectin-3 and -8 ligands in bronchoalveolar lavage of mild asthmatics and healthy subjects. Biochim Biophys Acta 1820, 1429-1436.
    26. Carlsson MC, Bakoush O, Tengroth L, Kilsgård O, Malmström J, Hellmark T, Segelmark M, Leffler H (2012) Galectin-8 in IgA Nephritis: Decreased Binding of IgA by Galectin-8 Affinity Chromatography and Associated Increased Binding in Non-IgA Serum Glycoproteins. J Clin Immunol 32, 246-255.
    27. Oehmcke S, Mörgelin M, Malmström J, Linder A, Chew M, Thorlacius H, Herwald H (2012) Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. Cell Microbiol 14, 107-119. (Abstract)
    28. Ali A, Moushib L, Lenman M, Levander F, Olsson K, Carlson-Nilson U, Zoteyeva N, Liljeroth E, Andreasson E (2012) Paranoid potato: Phytophthora resistant genotype shows constitutively activated defense. Plant Signal Behav 7, 400-408.
    29. Karlsson C, Malmström L, Aebersold R, Malmström J (2012) Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes. Nat Commun 3:1301. (Abstract)
    30. Nordenfelt P, Waldemarson S, Linder A, Mörgelin M, Karlsson C, Malmström J, Björck L (2012) Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med 209, 2367-2381. (Abstract)


    1. Lindstedt M, Nelissen I, Gibbs S, Borrebaeck CAK (2011) Mimicking the immunoregulatory properties of primary dendritic cells in vitro − A rational approach to design a test system.Chapter 5, page 67-86. In: Progress towards novel testing strategies for in vitro assessment of allergens. (Eds. Roggen EL, Weltzien HU, Hermans H), Transworld Research Network, Kerala, India, pp. 67-86.
    2. Corsini E, Aeby P, Python F, Nelissen I, Kjær T, Gibbs S, dos Santos G, Lindstedt M, Borrebaeck C, Roggen E (2011) The use of myeloid cell lines for the identification of allergens. In: Progress towards novel testing strategies for in vitro assessment of allergens. (Eds. Roggen EL, Weltzien HU, Hermans H), Transworld Research Network, Kerala, India, pp. 103-116.
    3. Lindstedt M, Borrebaeck CAK (2011) Pattern rules - biomarker signatures for sensitization as an alternative to animal testing. Biomarkers Med 5, 809-811.
    4. Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, Jirström K, Borrebaeck CAK, Ek S (2011)The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer 11, 405. (Abstract)
    5. Borrebaeck CAK, Wingren C (2011) Recombinant antibodies for the generation of antibody arrays. Methods Mol Biol 785, 247-262. (Abstract)
    6. Gunnarsson A, Dexlin-Mellby L,Wallin P, Svedhem S, Jönsson P, Wingren C, Höök, F (2011) Kinetics of ligand binding to membrane-receptors from equilibrium fluctuation analysis of single binding events. J Am Chem Soc 38, 14852-14855. (Abstract)
    7. Conrotto P, Andréasson U, Kuci V, Borrebaeck CAK, Ek S (2011) Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo. Mol Oncol 5, 527-537. (Abstract)
    8. Carlsson A, Wingren C, Kristensson M, Rose C, Fernö M, Olsson H, Jernström H, Ek S, Gustavsson E, Ingvar C, Ohlsson M, Peterson C, Borrebaeck CAK (2011) Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases. Proc Natl Acad Sci 108, 14252-14257. (Abstract)
    9. Johansson H, Lindstedt M, Albrekt AS, Borrebaeck CAK (2011) A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics 12, 399 (Abstract)
    10. Olsson N, Wingren C, Mattsson M, James P, O'Connell D, Nilsson F, Cahill DJ, Borrebaeck CAK (2011) Proteomic analysis and discovery using affinity proteomics and mass spectrometry. Mol Cell Proteomics 10, M110.003962. (Abstract)
    11. Welinder C, Baldetorp B, Borrebaeck C, Fredlund BM, Jansson B (2011) A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti tumour activity. Glycobiology 21, 1097-1107. (Abstract)
    12. Lundberg K, Broos S, Greiff L, Borrebaeck CAK, Lindstedt M (2011) Histamine H4 receptor antagonism inhibits allergen-specific T-cell responses mediated by human dendritic cells. Eur J Pharmacol 651, 197-204. (Abstract)
    13. Gustavsson E , Ek S, Steen J, Kristensson M, Älgenäs C, Uhlén M, Wingren C, Ottosson J, Hober S, Borrebaeck CAK (2011) Surrogate antigens as targets for proteome-wide binder selection. N Biotechnol 28, 302-311. (Abstract)
    14. Reinhard H, Le VTK, Ohlin M, Hengel H, Trilling M (2011) Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS ONE 6, e14532 (Abstract)
    15. Centlow M, Wingren C, Borrebaeck CAK, Brownstein MJ, Hansson SR (2011) Differential gene expression analysis of placentas with increased vascular resistance and preeclampsia using whole genome microarrays. J Pregnancy article ID 472354 (Abstract)
    16. Levin M, Tan LW, Baker L, Wormald PJ, Greiff L, Ohlin M (2011) Diversity of IgE-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis. Clin Exp Allergy 41, 811-820. (Abstract)
    17. Dexlin-Mellby L, Sandström A, Antberg L, Karlsson J, Hansson SR, Borrebaeck CAK, Wingren C (2011) Design of recombinant antibody microarrays for membrane protein profiling of cell lysates and tissue extracts. Proteomics 11, 1550-1554. (Abstract)
    18. Carlsson A, Wuttge DM, Ingvarsson J, Bengtsson AA, Sturfelt G, Borrebaeck CAK, Wingren C (2011) Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Mol Cell Proteomics 10, M110.005033 (Abstract)
    19. Magnusson K, de Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen, S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CAK, Navani S, Uhlén M, O’Connor DP, Jirström K, Pontén F (2011) SATB2 in combination with Cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surgical Pathol 35, 937-948. (Abstract)
    20. James P (2011) The international proteomics tutorial programme: A teaching tool box for the proteomics community. Proteomics 11, 3596-7
    21. Cifani P, Bendz M, Wårell K, Hansson K, Levander F, Sandin M, Krogh M, Ovenberger M, Fredlund E, Vaapil M, Pietras A, Påhlman S, James P (2011)  Hunting for protein markers of hypoxia by combining plasma membrane enrichment with a new approach to membrane protein analysis. J. Proteome Res 10, 1645-1656. 
    22. Stella R, Biancotto G, Krogh M, Angeletti R, Pozza G, Sorgato M-C James P, Andrighetto I (2011) Protein expression changes in skeletal muscle in response to growth promoter abuse in beef cattle. J Proteome Res 10, 2744-2757.
    23. James P, Marko-Varga GA (2011) The international proteomics tutorial programme - reaching out to the next generation proteome scientists. J Proteome Res 10, 3311-3312.
    24. Fernandez C, Schuhmann K, Herzog R, Fielding B, Frayn K, Shevchenko A, James P, Holm C, Ström K (2011) Altered desaturation and elongation of fatty acids in hormone-sensitive lipase null mice. PLoS One. 6(6): e21603.
    25. Cox J, Heeren RM, James P, Jorrin-Novo JV, Kolker E, Levander F, Morrice N,Picotti P, Righetti PG, Sánchez JC, Turck CW, Zubarev R, Alexandre BM, Corrales FJ, Marko-Varga G, O'Donovan S, O'Neil S, Prechl J, Simões T, Weckwerth W, Penque D (2011) Facing challenges in Proteomics today and in the coming decade. J Proteomics 75, 4-17.
    26. Corthals GL, Dunn M, James P, Gil C, Penque D,  Albar JP,  Andrén P, Rabilloud T,  Markö-Varga G  (2011) The transition of European proteomics association into the future. J Proteomics 75 18-22.
    27. Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R (2011) The quantitative proteome of a human cell line. Mol Syst Biol 7, 549. (Abstract)
    28. Malmström L, Malmström J, Aebersold R (2011). Quantitative proteomics of microbes: Principles and applications to virulence. Proteomics 11, 2947-2956.
    29. Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, Mallick P, Katz JE, Malmström J, Ossola R, Watts JD, Lin B, Zhang H, Moritz RL, Aebersold R (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 10, M110.006353.
    30. Schmidt A, Beck M, Malmström J, Lam H, Claassen M, Campbell D, Aebersold R (2011) Absolute quantification of microbial proteomes at different states by directed mass spectrometry. Mol Syst Biol 7, 510.
    31. Sandin M, Krogh M, Hansson K, Levander F (2011) Generic workflow for quality assessment of quantitative label-free LC-MS analysis. Proteomics 11, 1114-1124.
    32. Martens L, Chambers M, Sturm M, Kessner D, Levander F, Shofstahl J, Tang WH, Römpp A, Neumann S, Pizarro AD (2011) mzML-a community standard for mass spectrometry data. Mol Cell Proteomics 10, R110.000133.
    33. Häkkinen J, Levander F (2011) Laboratory data and sample management for proteomics. Methods Mol Biol 696, 79-92.
    34. Deutsch EW, Chambers M, Neumann S, Levander F, Binz PA, Shofstahl J, Campbell DS, Mendoza L, Ovelleiro D, Helsens K (2011) TraML: a standard format for exchange of selected reaction monitoring transition lists. Mol Cell Proteomics, R111.015040.


    1. Borrebaeck CAK, Wingren C (2010) Developing and applying recombinant antibody microarrays for high-throughput disease proteomics. Eur Pharm Rev 6, 45-49.
    2. Széles L, Póliska S, Nagy G, Szatmari I, Szanto A, Pap A, Lindstedt M, Santegoets SJ, Rühl R, Dezsö B, Nagy L (2010) Research resource: Transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol Endocrinol 24, 2218-2231. (Abstract)
    3. Dexlin-Mellby L, Sandström A, Centlow M, Nygren S, Hansson SR, Borrebaeck CAK, Wingren C (2010) Tissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays. Proteomics Clin Appl 4, 794-807. (Abstract)
    4. Håkansson M, Logan DT, von Schantz L, Nordberg Karlsson E, Ohlin M (2010) Non-specific CBM4-2 variant X-2 L110F – apo, xylopentaose, cellopentaose structures. MAX-Lab Activity Report 2010 (Eds. Johansson U, Lilja K, Nyberg A, Nyholm R), MAX-Lab, Lund, Sweden. pp 338-339. (report)
    5. Lundberg K, Greiff L, Borrebaeck CAK, Lindstedt M (2010) FcεRI levels and frequencies of peripheral blood dendritic cell populations in allergic rhinitis. Hum Immunol 71, 931-933. (Abstract)
    6. Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, Borrebaeck CAK, Ek S (2010) SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer 9, 187. (Abstract)
    7. Bourbeillon J, Orchard S, Benhar I, Borrebaeck C, de Daruvar A, Dübel S, Frank R, Gibson F, Gloriam D, Haslam N, Hiltker T, Humphrey-Smith I, Hust M, Juncker D, Koegl M, Konthur Z, Korn B, Krobitsch S, Muyldermans S, Nygren P-Å, Palcy S, Polic B, Rodriguez H, Sawyer A, Schlapshy M, Snyder M, Stoevesandt O, Taussig MJ, Templin M, Uhlén M, van der Maarel S, Wingren C, Hermjakob H, Sherman D (2010) Minimum Information about a Protein Affinity Reagent (MIAPAR). Nat Biotechnol 28, 650-653. (Abstract)
    8. Broos S, Lundberg K, Akagi T, Kadowaki K, Akashi M, Greiff L, Borrebaeck CAK, Lindstedt M (2010) Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy. Vaccine 28, 5075-5085. (Abstract)
    9. Jensen RL, Städe LW, Wimmer R, Stensballe A, Duroux M, Larsen KL, Wingren C and Duroux L (2010) Direct site-directed photocoupling of proteins onto surfaces coated with β-cyclodextrins. Langmuir 26, 11597-11604. (Abstract)
    10. Andréasson U, Edén P, Peterson C, Högerkorp CM, Jerkeman M, Andersen N, Berglund M, Sundström C, Rosenquist R, Borrebaeck CAK and Ek S (2010) Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples. Am J Hematol 85, 418-425. (Abstract)
    11. Sandquist D, Filonova L, von Schantz L, Ohlin M and Daniel G (2010) Microdistribution of xyloglucan in differentiating poplar cells. BioResources 5, 796-807. (pdf)
    12. Kobayashi N, Oyama H, Kato Y, Goto J, Söderlind E and Borrebaeck CAK (2010) Two-step in vitro antibody affinity maturation enables estradiol-17β assays with more than 10-fold higher sensitivity. Anal Chem 82, 1027-1038. (Abstract)
    13. Carlsson A, Persson O, Ingvarsson J, Widegren B, Salford L, Borrebaeck CAK and Wingren C (2010) Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients. Proteomics Clin Appl 4, 591-602. (Abstract)
    14. Gloriam DE, Orchard S, Bertinetti D, Björling E, Bongcam-Rudloff E, Bourbeillon J, Bradbury AR, de Daruvar A, Dübel S, Frank R, Gibson TJ, Haslam N, Herberg FW, Hiltke T, Hoheisel JD, Kerrien S, Koegl M, Konthur Z, Korn B, Landegren U, van der Maarel S, Montecchi-Palazzi L, Palcy S, Rodriguez H, Schweinsberg S, Sievert V, Stoevesandt O, Taussig MJ, Uhlén M, Wingren C, Gold L, Woollard P, Sherman DJ and Hermjakob H (2010) A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics 9, 1-10. (Abstract)
    15. Persson O, Salford LG, Fransson J, Widegren B, Borrebaeck CAK and Holmqvist B (2010) Distribution, cellular localization and therapeutic potential of the tumor associated antigen Ku70/80 in glioblastoma multiforme. J Neurooncol 97, 207-215 (Abstract)
    16. Gullfot F, Tan T-C, von Schantz L, Nordberg Karlsson E, Ohlin M, Brumer H and Divne C (2010) The crystal structure of XG-34, an evolved xyloglucan-specific carbohydrate binding module. Proteins 78, 785-789. (Abstract) (protein structure)
    17. Persson H, Persson J, Danielsson L and Ohlin M (2010) Charges drive selection of specific antibodies by phage display. J Immunol Methods 353, 24-30. (Abstract)
    18. Gustafsson E, Rosén A, Barchan K, van Kessel KPM, Haraldsson K, Lindman S, Forsberg C, Ljung L, Bryder K, Walse B, Haas P-J, van Strijp JAG and Furebring C (2010) Directed evolution of Chemotaxis Inhibitory Protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies. Protein Eng Des Sel 23, 91-101. (Abstract)
    19. Cappadona S, Nanni P, Benevento M, Levander F, Versura P, Roda A, Cerutti S, Pattini L, Tang K (2010) Improved label-free LC-MS analysis by wavelet-based noise rejection. J Biomed Biotechnol 2010, 131505.


    1. Gustafsson E, Forsberg C, Haraldsson K, Lindman S, Ljung L and Furebring C (2009) Purification of truncated and mutated chemotaxis inhibitory protein of Staphylococcus aureus  - an anti-inflammatory protein. Protein Expres Purif 63, 95-101. (Abstract) [Epub ahead of print Oct 5, 2008]
    2. Larsson K, Lindstedt M, Lundberg K, Dexlin L, Wingren C, Korsgren M, Greiff L, Borrebaeck CAK (2009) CD4+ T-cells have a key instructive role in educating dendritic cells in allergy. Int Arch Allergy Immunol 149, 1-15. (Abstract) [Epub ahead of print Nov 26, 2008]
    3. Augustsson P, Persson J, Ekström S, Ohlin M and Laurell T (2009) Decomplexing biofluids using microchip based acoustophoresis. Lab Chip 9, 810 - 818. (Abstract) [Epub ahead of print Dec 1, 2008]
    4. Fransson J and Borrebaeck CAK (2009) Selection and characterization of antibodies from phage display libraries against internalizing membrane antigens. Methods Mol Biol 480, 1-15. (Abstract)
    5. Wingren C and Borrebaeck CAK (2009) Antibody-based microarrays. Methods Mol Biol 509, 57-84. (Abstract)
    6. Borrebaeck CAK and Wingren C (2009) Transferring proteomic discoveries into clinical practice. Expert Rev Proteomics 6, 11-13. (Abstract)
    7. Gustafsson E, Haas P-J, Walse B, Hijnen M, Furebring C, Ohlin M, van Strijp JAG and van Kessel KPM (2009) Identification of conformational epitopes for human IgG on chemotaxis inhibitory protein of Staphylococcus aureus. BMC Immunol 10, 13. (Abstract)
    8. Wingren C, James P and Borrebaeck CAK (2009) Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics 9, 1511-1517. (Abstract)
    9. Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannely G, O´Connor DP, Gallagher W, Kilpinen S, Kallioniemi OP, Jirström K, O´Herlihy C and Borrebaeck CAK (2009) The transcription factor Sox11 is a prognostic factor for Improved recurrence free survival in epithelial ovarian cancer. Eur J Cancer 45, 1510-1517. (Abstract)
    10. Nyström J, Hultenby K, Ek S, Sjölund J, Axelson H, Jirström K, Saleem MA, Nilsson K and Johansson ME (2009) CRIM1 is localized to the podocyte filtration slit diaphragm of the adult human kidney. Nephrol Dial Transplant 24, 2038-2044. (Abstract)
    11. Borrebaeck CAK and Wingren C (2009) Design of high-density antibody microarrays for disease proteomics: Key technological issues. J Proteomics 72, 928-935. (Abstract)
    12. Axelsson F, Persson J, Moreau E, Côté MH, Lamarre A and Ohlin M (2009) Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology. N Biotechnol 25, 429-436. (Abstract)
    13. Persson J, Bäckström M, Johansson H, Jirström K, Hansson GC and Ohlin M (2009) Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumour cells. Tumor Biol 30, 221-231. (Abstract)
    14. Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadström T and Borrebaeck CAK (2009) Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 94, 1563-1568. (Abstract)
    15. Brodin E, Ohlin M and Lindén J (2009)  Mentorskap i forskarutbildningen: doktoranders, mentorers och handledares syn på lärande i forskarutbildningen. In: Sonesson A and Amnér G (Eds.) Proceedings of Utvecklingskonferens 09, Lunds universitet, Lund, Sweden. pp 14-20.
    16. Andréasson U, Dictor M, Jerkeman M, Berglund M, Högerkorp C-M, Sundström C, Rosenquist R, Eden P, Borrebaeck CAK and Ek S (2009) Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumour cells. Am J Hematol 84, 803-808. (Abstract)
    17. Ellmark P, Ghatnekar-Nilsson S, Meister A, Heinzelmann H, Montelius L, Wingren C and Borrebaeck CAK (2009) Attovial-based antibody nanoarrays. Proteomics 9, 5406-5413. (Abstract)
    18. von Schantz L, Gullfot F, Scheer S, Filonova L, Cicortas Gunnarsson L, Flint JE, Daniel G, Nordberg-Karlsson E, Brumer H and Ohlin M (2009) Affinity maturation generates greatly improved xyloglucan-specific carbohydrate binding modules. BMC Biotechnol 9, 92. (Abstract)
    19. Weltzien HU, Corsini E, Gibbs S, Lindstedt M, Borrebaeck C, Budde P, Schulz-Knappe P, Thierse HJ, Martin SF, Roggen EL (2009)  Safe cosmetics without animal testing? Contributions of the EU Project Sens-it-iv. J Verbr Lebensm 4 (Suppl 2), S41–S48. (Abstract)
    20. Tessari P, Iori E, Puricelli L, Arrigoni G,  Vedovato M, Trevisan R, James P, Tiengo A, Millioni R (2009) Abnormal cytoskeletal protein expression in cultured skin fibroblasts from type 1 diabetes mellitus patients with nephropathy. Proteomics 2, 492-503.
    21. Nanni P, Mezzanottea L, Roda G, Caponi A, Levander F, James P, Roda A (2009)  Differential proteomic analysis of HT29 Cl.16E cells line and intestinal epithelial cells by LC ESI/QTOF mass spectrometry. J Proteomics 72, 865-873 
    22. Nanni P, Levander F, Roda G, Caponi A, James P, Roda A (2009) Serum protein biomarker discovery in inflammatory bowel diseases by label-free liquid chromatography electrospray ionization-quadrupole/Time-of-Flight mass spectrometry differential analysis. J Chrom B 877, 3127-3136.
    23. Fernandez C, Krogh M, Wårell K, Alm K, Oredsson S, Persson L, James P, Holm C (2009) Omics analyses reveal a potential link between hormone-sensitive lipase and polyamine metabolism. J Proteome Res 8, 5008-5019.
    24. Bendz M, Carlsson Möller M, Arrigoni G, Wåhlander Å, Stella R, Cappadona S, Levander F,  Hederstedt L, James P (2009) Quantification of membrane proteins using non-specific protease digestions. J Proteome Res  8, 5666-5673.
    25. Bertipaglia I, Bourg N, Richard I, Pahlman AK, Andersson L, James P, Carafoli E (2009) A proteomic study of calpain-3 and its involvement in limb girdle muscular dystrophy type 2a. Cell Calcium 46, 356-363.
    26. Eisenacher M, Martens L, Hardt T, Kohl M, Barsnes H, Helsens K, Hakkinen J, Levander F, Aebersold R, Vandekerckhove J (2009) Getting a grip on proteomics data-Proteomics Data Collection (ProDaC). Proteomics 9, 3928-3933.
    27. Persson O, Brynnel U, Levander F, Widegren B, Salford LG, Krogh M (2009) Proteomic expression analysis and comparison of protein and mRNA expression profiles in human malignant gliomas. Proteomics Clin Appl 3, 83-94
    28. Karhumaa K, Påhlman AK, Hahn-Hägerdal B, Levander F, Gorwa-Grauslund MF (2009) Proteome analysis of the xylose-fermenting mutant yeast strain TMB 3400. Yeast 26, 371-382.
    29. Häkkinen J, Vincic G, Månsson O, Wårell K, Levander F (2009) The proteios software environment: an extensible multiuser platform for management and analysis of proteomics data. J Proteome Res 8, 3037-3043.
    30. Eisenacher M, Kohl M, Martens L, Barsnes H, Hardt T, Levander F, Häkkinen J, Apweiler R, Meyer HE, Stephan C (2009) Proteomics data collection-4th ProDaC workshop 15 August 2008, Amsterdam, The Netherlands. Proteomics 9, 218-222.


    1. Ek S, Dictor M, Jerkeman M, Jirström K and Borrebaeck CAK (2008) Nuclear expression of the non-B cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 111, 800-805. (Abstract) [Epub ahead of print Oct 12, 2007]
    2. Dexlin L, Ingvarsson J, Frendéus B, Borrebaeck CAK and Wingren C (2008) Membrane protein profiling of intact cells using recombinant antibody microarrays. J Proteome Res 7, 319-327. (Abstract) [Epub ahead of print Nov 30, 2007]
    3. Ellmark P, Andersson H, Abayneh S, Fenyö EM and Borrebaeck CAK (2008) Identification of a strongly activating human anti-CD40 antibody that suppresses  HIV-1 infection. AIDS Res Hum Retroviruses 24, 367-373. (Abstract)
    4. Abayneh SA, Ellmark P, Karlsson U, Andersson H, Borrebaeck CAK, Karlsson I and Fenyö EM (2008) Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use. AIDS Res Hum Retroviruses 24, 447-452. (Abstract)
    5. Ellmark P, Woolfson A, Belov L and Christopherson RI (2008) The applicability of a cluster of differentiation monoclonal antibody microarrays to the diagnosis of human disease. In: Genomic protocols 2nd ed. (Eds. Starkey M and Elaswarapu R). Meth Mol Biol vol. 439, Humana Press, Totowa, NJ, USA, pp. 199-209. (Abstract)
    6. Andréasson U, Ek S, Merz H, Rosenquist R, Andersen N, Jerkeman M, Dictor M and Borrebaeck CAK (2008) B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule. Cancer Lett 259, 138-245. (Abstract) [Epub Dec 3, 2007]
    7. Ortega-Paino E, Fransson J, Ek S and Borrebaeck CAK (2008) Functionally-associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference. Blood 111, 1617-1624. (Abstract) [Epub Nov 16, 2007]
    8. Wingren C and Borrebaeck CAK (2008) Antibody microarray analysis of directly labelled complex proteomes. Curr Opin Biotechnol 19, 55-61. (Abstract)
    9. Carlsson A, Wingren C, Ingvarsson J, Ellmark P, Baldertorp, Fernö M, Olsson H and Borrebaeck CAK (2008) Serum protein profiling of metastatic breast cancer using recombinant antibody microarrays". Eur J Cancer 44, 472-480. (Abstract) [Epub Dec 31, 2007]
    10. Persson H, Flicker S, Karbalaei Sadegh M, Valenta R, Greiff L and Ohlin M (2008) A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2. Mol Immunol 45, 2715-2720. (Abstract)
    11. Ellmark P, Högerkorp CM, Ek S, Belov L, Berglund M, Christopherson RI, and Borrebaeck CAK (2008) Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Lett 265, 98-106. (Abstract)
    12. Ingvarsson J, Wingren C, Carlsson A, Ellmark P, Wahren B, Engström G, Harmenberg U, Krogh M, Peterson C, Borrebaeck CAK (2008) Detection of pancreatic cancer using antibody microarray-based serum protein profiling. Proteomics 8, 2211-2219. (Abstract) (journal cover )
    13. Wingren C and Borrebaeck CAK (2008) Antibody microarray-based proteomics: High-throughput application. Bioforum Europe. 2008, 46-47.
    14. Wingren C and Borrebaeck CAK Antibody microarray-based screening:  Label-dependent vs. Label-free detection. Scr Trend Drug Discov 2/2008, 12-14.
    15. Lundberg K, Lindstedt M, Larsson K, Dexlin L, Wingren C, Ohlin M,
      Greiff L and Borrebaeck CAK (2008) Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4. Clin Immunol 128, 358-365. (Abstract)
    16. Santegoets S, Gibbs S, Kroeze K, van de Ven R, Scheper RJ, Borrebaeck CAK, de Gruijl TD and Lindstedt M (2008) Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol 84, 143-151. (Abstract)
    17. Persson H, Wallmark H, Ljungars A, Hallborn J and Ohlin M (2008) In vitro evolution of an antibody fragment population to find high affinity hapten binders. Protein Eng Des Sel 21, 485-493. (Abstract)
    18. Ohlin M (2008) Handledning, återkoppling och bedömning i utbildning på forskarnivå. Finns det ett behov av förändring? In: Sonesson A and Hedberg M (Eds.) Proceedings NU2008. CED, Lund, Sweden. pp 117-119. (Full text)
    19. Persson J, Augustsson P, Laurell T and Ohlin M (2008) Acoustic microfluidic chip technology to facilitate automation of phage display selection. FEBS J 275, 5657-5666. (Abstract) (journal cover )
    20. Sekula S, Fuchs J, Weg-Remers S, Nagel P, Schuppler S, Fragala J, Theilacker N, Franzreb M, Wingren C, Ellmark P, Borrebaeck CAK, Mirkin CA, Fuchs H and Lenhert S (2008) Multiplexed lipid dip-pen nanolithography on subcellular scales for the templating of functional proteins and cell culture. Small 4, 1785-1793. (Abstract) (journal cover )
    21. Wingren C and Borrebaeck CAK (2008) Protein microarray technologies for detection and identification of bacterial and protein analytes. In: Zourob M, Elwary S and Turner A (Eds.) Principles of bacterial detection: Biosensors, recognition receptors and microsystems. Springer, Heidelberg, Germany. pp 715-729.
    22. Naurin S, Bensch S, Hansson B, Johansson T, Clayton DF, Albrekt A-S, von Schantz T and Hasselqvist D (2008) A microarray for large-scale genomic and transcriptional analyses of the zebra finch (Taeniopygia guttata) and other passerines. Mol Ecol Resources 8, 275-281 (Abstract)
    23. Håkansson M, Logan DT, von Schantz L, Nordberg Karlsson E, Ohlin M (2008) Engineered CBM4-2 variant X-2 – apo, xylotetrose, xylopentose structures. MAX-Lab Activity Report 2008 (Eds. Johansson U, Nyberg A, Nyholm R, Ullman H), MAX-Lab, Lund, Sweden. pp 368-369. (report)
    24. Fernandez C, Fransson U, Hallgard E, Spégel P, Holm C, Krogh M, Wårell K, James P, Mulder H (2008) Metabolomic and proteomic analysis of a clonal insulin-producing b-cell line. J Proteome Res 7, 400-411 
    25. Jansson M, Wårell K, Levander F, James P (2008) N-terminal labelling of non-tryptic membrane protein peptides facilitates database searching. J Proteome Res 7, 659-665.
    26. Arrigoni G, Pagano MA, Cesaro L, Sarno S, James P, Pinna L (2008) Identification of putative interacting partners of protein kinase CK2 beta subunit by affinity chromatography and mass spectrometry. J Proteome Res 7, 990-1000.
    27. Mathivanan, S., et al. (2008)  Human Proteinpedia: A portal for sharing and integration of human protein data. Nature Biotechnology. 26(2): 164-7.
    28. Wåhlander Å, Arrigoni G, Snel M, Hellman U, James P (2008)  Parallel post-source decay for increasing protein identification confidence levels from 2D gels. Proteomics 8, 1771-1779.
    29. Lottspeich F, Dunn MJ, Pennington S, Sanchez J-C, Gil C, Kleinhammer C, Hoogland C, Bini L, Quinn A, Noukakis D, Novo JJ, Albar J-P, Corthals G, James P, Palagi PM, Penque D (2008) EuPA achieves visibility – An activity report on the first three years. J Proteomics 71, 11-18. 
    30. Cappadona S, Levander F, James P, Cerutti S, Pattini L (2008)  A wavelets-based method for noise characterisation and rejection in high-performance liquid chromatography coupled to mass spectrometry. Anal Chem 80, 4960-4968.
    31. Iori E, Millioni R, Puricelli L, Arrigoni G, Lenzini L,  Trevisan R, James P, Rossi GP, Pinna LA, Tessari P  (2008) Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy. Biochim Biophys Acta 1782, 627-633.
    32. Bruzelius K, Purup S, James P, Önning G, Åkesson B (2008) Biosynthesis of selenoproteins in cultured bovine mammary cells. J Trace Elements Med Biol 22, 224-233
    33. De Iuliis A, Arrigoni G, Andersson L, Zambenedetti P, Burlina A, James P, Arslan P, Vianello F (2008)  Oxidative metabolism of dopamine: a colour reaction from human midbrain analysed by mass spectrometry. Biochim Biophys Acta 1784, 1687-1693.
    34. Eisenacher M, Hardt T, Hamacher M, Martens L, Häkkinen J, Levander F, Apweiler R, Meyer HE, Stephan C (2008) Proteomics Data Collection-2nd ProDaC Workshop 5 October 2007, Seoul, Korea. Proteomics 8, 1326-1330.


    1. Barrios Y, Knör S, Lantto J, Mach M and Ohlin M (2007) Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties. Mol Immunol 44, 680-690. [Epub ahead of print July 7, 2006] (Abstract)
    2. Persson H and Ohlin M (2007) Exploring central and peripheral diversity in antibody evolution. Mol Immunol 44, 2729-2736. (Abstract)
    3. Ghatnekar-Nilsson S, Dexlin L, Wingren C, Montelius L and Borrebaeck CAK (2007) Design of atto-vial based recombinant antibody arrays combined with a planar wave guide detection system. Proteomics 7, 540-547. (Abstract)
    4. Taussig MJ, Stoevesandt O, Borrebaeck CAK, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dübel S, Eichler J, Frank R, Gibson TJ, Gloriam D, Gold L, Herberg FW, Hermjakob H, Hoheisel JD, Joos TO, Kallioniemi O, Koegll M, Konthur Z, Korn B, Kremmer E, Krobitsch S, Landegren U, van der Maarel S, McCafferty J, Muyldermans S, Nygren PÅ, Palcy S, Plückthun A, Polic B, Przybylski M, Saviranta P, Sawyer A, Sherman DJ, Skerra A, Templin M, Ueffing M, Uhlén M (2007) ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods 4, 13-17. (Abstract)
    5. Zhou Y, Xu H, Dahlin A, Vallkil J, Borrebaeck CAK, Wingren C, Liedberg B and Höök F. (2007) Quantitative interpretation of of gold nanoparticle-based bioassays designed for detection of immuno-complex formation. Biointerphases 2, 6-15 (Abstract).
    6. Wingren C and Borrebaeck CAK (2007) Antibody microarray-based proteomics. High Throughput Application. Bioforum Europe 2007, 34-35.
    7. Cicortas Gunnarsson L, Montanier C, Tunnicliffe RB, Williamson MP, Gilbert HJ, Nordberg Karlsson E and Ohlin M (2007) Novel xylan-binding properties of an engineered family 4 carbohydrate-binding module. Biochem J 406, 209-214. (Abstract)
    8. Persson H, Karbalaei Sadegh M, Greiff L and Ohlin M (2007) Delineating the specificity of an IgE-encoding transcriptome. J Allergy Clin Immunol 120, 1186-1192. (Abstract) (see comment in the journal's Editors' choice section)
    9. Ingvarsson J, Larsson A, Sjöholm AG, Truedsson L, Jansson B, Borrebaeck CAK and Wingren C (2007) Design of Recombinant Antibody Microarrays for Serum Protein Profiling: Targeting of Complement Proteins. J Proteome Res 6, 3527-3536 (Abstract)
    10. Ohlin M (2007) Formativ examination i utbildning på forskarnivå – möjligheter till förändring. In: Proceedings of Utvecklingskonferens LU 2007, Lund University, Lund, Sweden. (in Swedish) (pdf-file) (complete conference proceedings)
    11. Wingren C, Ingvarsson J, Dexlin L, Szul D and Borrebaeck CAK (2007) Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labeling-tag and solid support. Proteomics 7, 3055-3065. (Abstract)
    12. Augustsson P, Persson J, Ohlin M and Laurell T (2007) On-chip affinity selection of antibodies using ultrasonic standing waves. In: Viovy J-L, Tabeling P, Descroix S and Malaquin L (Eds.) Micro Total Analysis Systems 2007. Proceedings of µTAS 2007. 11th International Conference on Miniaturized Systems for Chemistry and Life Sciences, Vol. 2. Chemical and Biological Microsystems Society, San Diego, CA, USA, pp. 1810-1812.
    13. Wingren C and Borrebaeck CAK (2007) Progress in miniaturization of protein arrays - a step closer to high-density nanoarrays. Drug Discov Today 12, 813-819. (Abstract)
    14. Borrebaeck CAK and Wingren C (2007) High-throughput proteomics using antibody microarrays: an update. Expert Rev Mol Diagn 7, 673-686. (Abstract)
    15. Filonova L, Cicortas Gunnarsson L, Daniel G and Ohlin M (2007) Synthetic xylan-binding modules for mapping of pulp fibres and wood sections. BMC Plant Biol 7, 54. (Abstract)
    16. Ek S and Borrebaeck CAK (2007) Parallel gene expression profiling of Mantle cell lymphoma - How do we transform 'omics data into clinical practice. Curr Genomics 8, 171-179. (Abstract)
    17. Ohlin M (2007) Bedömning, återkoppling och examination i utbildning på forskarnivå - vad är i fokus? Lärande i LTH 2, 2-3. (in Swedish) (pdf-file)
    18. Axelsson F, Adler SP, Lamarre A and Ohlin M (2007) Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines. Vaccine 26, 41-46. (Abstract)
    19. Duroux M, Skovsen E, Neves-Petersen MT, Duroux L, Gurevich L, Borrebaeck CAK, Wingren C and Petersen SB (2007) Light-induced immobilisation of biomolecules as an attractive alternative to microdroplet dispensing-based arraying technologies. Proteomics 7, 3491 - 3499 (2008: 8, 1113).
    20. Duroux M, Gurevich L, Neves-Petersen MT, Skovsen E, Duroux L, Borrebaeck CAK, Wingren C and Petersen SB (2007) Using light to bioactivate surfaces: A new way of creating oriented, active immunobiosensors. Appl Surf Sci 254, 1126-1130. (Abstract)
    21. Rogstam A, Linse S, Lindqvist A, James P, Wagner L, Berggård T (2007) Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J 401, 353-363. 
    22. Tessari P, Puricelli L, Iori E, Arrigoni G, Vedovato M, James P, Coracina A, Millioni R (2007) Altered chaperone and protein turnover regulators expression in skin fibroblasts from type 1 diabetes mellitus with nephropathy. J Proteome Res 6, 976-986.
    23. Levander F, Krogh M, Wårell K, Gärdén P, James P, Häkkinen J (2007) Automated reporting from gel-based proteomics experiments using the open source Proteios database application. Proteomics 7, 668-674.
    24. Andersson T, Johansson M, Bolmsjö G, James P (2007) Automating MALDI sample plate loading. J Proteome Res 6, 894-896.
    25. Wåhlander Å, Arrigoni G, Levander F, Wårell K, James P (2007) Development of reagents for differential protein quantitation by subtractive parent ion scanning. J Proteome Res 6, 1101-1113.
    26. Bengtsson S, Krogh M, Al-Khalili Szigyarto C, Uhlén M, Schedvins K, Silfversward C, Linder S, Auer G, Alaiya A, James P (2007) Large-Ssale proteomics analysis of human ovarian cancer for biomarkers. J Proteome Res 6, 1440-1450.
    27. Lindh R, Ahmad F, Resjo S, James P, Yang JS, Fales HM, Manganiello V, Degerman E.  (2007) Multisite phosphorylation of adipocyte and hepatocyte phosphodiesterase 3B. Biochim Biophys Acta 1773, 584-592.
    28. Liu Z, Bengtsson S, Krogh M, Marquez M, Nilsson S, James P, Alaiya A, Holmberg A (2007) Somatostatin effects on the proteome of the LNCaP Cell line. Int J Oncol 30, 1173-1179.
    29. Valastro B, Dekundy A, Krogh M, James P, Danysz W, Quack G, Cenci A (2007)  Proteomic analysis of striatal proteins in the L-DOPA-induced dyskinesia rat model. J Neurochem 102, 1395-1409. 
    30. Krogh M, Fernandez C, Teilum M, Bengtsson S, James P (2007) A probabilistic treatment of the missing spot problem in 2D gel electrophoresis experiments.  J Proteome Res 6, 3335-3343.
    31. Berggård T, Linse S, James P (2007) Methods for the detection and analysis of protein-protein interactions. Proteomics. 7, 2833-2842. 
    32. Krogh M,  Liu Y, Waldemarson S,  Fernandez C,  Valestro B, James, P  (2007)  Analysis of DIGE data using a linear mixed model allowing for protein-specific dye effects. Proteomics 7, 4235-4244.
    33. Albar JP, Corthals GL, Gil C, James P, Palagi PM, Penque D (2007) Promoting proteomics knowledge in Europe. Proteomics 7 Suppl 1, 90-94.
    34. Eisenacher M, Hardt T, Hamacher M, Martens L, Häkkinen J, Levander F, Apweiler R, Meyer HE, Stephan C (2007) Proteomics Data Collection-the 1st ProDaC workshop 26 April 2007 Ecole Normale Superieur, Lyon, France. Proteomics 7, 3034-3037.


    1. Roggen EL, Lindstedt M, Borrebaeck C and Verheyen GR. (2006) Interactions between dendritic cells and epithelial cells in allergic disease. Toxicol Lett 162, 71-82. [Epub ahead of print Nov 21, 2005] (Abstract)
    2. Ingvarsson J, Lindstedt M, Borrebaeck CAK and Wingren C (2006) One-step fractionation of complex proteomes enables detection of low abundant analytes using antibody-based microarrays. J Proteome Res 5, 170-176. (Abstract)
    3. Ek S, Björck E, Högerkorp C-M, Nordenskjöld M, Porwit-MacDonald A, Borrebaeck CAK (2006) Mantle cell lymphomas acquire expression of CCL4, CCL5 and 4-1BB implicated in cell survival. Int J Cancer 118, 2092-2097 [Epub ahead of print Nov 14, 2005] (Abstract)
    4. Larsson K, Lindstedt M and Borrebaeck CAK (2006) Functional and transcriptional profiling of MUTZ-3. A myeloid cell line acting as a model for dendritic cells. Immunology 117, 155-166. (Abstract)
    5. Cicortas Gunnarsson L, Dexlin L, Nordberg Karlsson E, Holst O and Ohlin M (2006) Evolution of a carbohydrate binding module into a protein-specific binder. Biomol Eng 23, 111-117. (Abstract)
    6. Cicortas Gunnarsson L, Nordberg Karlsson E, Andersson M, Holst O and Ohlin M (2006) Molecular engineering of a thermostable carbohydrate-binding module. Biocatal Biotransfor 24, 31-37. (Abstract)
    7. Fransson J, Tornberg U-K, Borrebaeck CAK, Carlsson R, and Björn Frendéus B (2006) Rapid induction of apoptosis in B cell lymphoma by functionally isolated human antibodies. Int J Cancer 119, 349-358. (Abstract)
    8. Persson H, Lantto J and Ohlin M (2006) Creating a focused antibody library for improved hapten recognition. J Mol Biol 357, 607-620. (Abstract)
    9. Johansson R, Ohlin M, Jansson B and Ohlson S (2006) Transiently binding antibody fragments against Lewis x and sialyl-Lewis x. J Immunol Methods 312, 20-26. (Abstract)
    10. Larsson A, Peng S, Persson H, Rosenblom J, Abrams WR, Wassberg E, Thelin S, Sletten K, Gerwins P and Westermark P (2006) Lactadherin binds to elastin - a starting point for amyloid formation? Amyloid 13, 78-75. (Abstract)
    11. Ek S, Andréasson U, Hober S, Kampf C, Pontén F, Uhlén M, Merz H, Borrebaeck CAK (2006) From gene expression analysis to tissue microarrays - a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol Cell Proteomics 5, 1072-1081 (Abstract)
    12. Karlsson F, Malmborg-Hager, A-C and Borrebaeck CAK (2006) Escherichia coli TolA tolerates multiple amino acid substitutions as revealed by screening randomised variants for membrane integrity and phage receptor function. FEMS Microbiol Lett 259, 81-88. (Abstract)
    13. Wingren C and Borrebaeck CAK (2006) Recombinant antibody microarrays: key technological issues. Scr Trend Drug Discov 02/2006, 13-15. (pdf-file)
    14. Steinhauer C, Wingren C, Khan F, He M, Taussig M and Borrebaeck CAK (2006) Improved affinity coupling for antibody microarrays: Engineering of double-(his)6-tagged single framework recombinant antibody fragments. Proteomics 6, 4227-4234. (Abstract)
    15. Wingren C (2006) Screening Europe 2006, Prague, Czech Republic, IDDB Meeting Report. In Investigational Drug DataBase (IDdb) ( Thompson Scientific, Philadelphia, PA, USA.
    16. Johansson R, Cicortas Gunnarsson L, Ohlin M and Ohlson S (2006) Thermostable carbohydrate-binding modules in affinity chromatography. J Mol Recognit 19, 275-281. (Abstract)
    17. Andréasson U, Flicker S, Lindstedt M, Valenta R, Greiff L, Korsgren M, Borrebaeck CAK and Ohlin M (2006) The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution. J Mol Biol 362, 212-227. (Abstract)
    18. Fransson J and Borrebaeck CAK (2006) The nuclear DNA repair protein Ku70/80 is a tumor-associated antigen displaying rapid receptor mediated endocytosis. Int J Cancer 119, 2492-2496. (Abstract)
    19. Wingren C (2006) First world congress meeting on OncoProteomics April 27-28, 2006, CA, USA. Expert Rev Proteomics 3, 267-270. (Abstract)
    20. Ellmark P, Ingvarsson J, Carlsson A, Lundin SB, Wingren C and Borrebaeck CAK (2006) Identification of protein expression signatures associated with H. pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 5, 1638-1646. (Abstract)
    21. Borrebaeck CAK (2006) Antibody microarray-based oncoproteomics. Expert Opin Biol Ther 6, 833-838. (Abstract)
    22. Högerkorp C-M and Borrebaeck CAK (2006) The human CD77- B cell population represents a heterogeneous subset of cells comprising centroblasts, centrocytes and plasmablasts, prompting phenotypical revision. J Immunol 177, 4341-4349. (Abstract)
    23. Cicortas Gunnarsson L, Zhou Q, Montanier C, Nordberg Karlsson E, Brumer H III and Ohlin M (2006) Engineered xyloglucan specificity in a carbohydrate-binding module. Glycobiology 16, 1171-1180. (Abstract)
    24. Woolfson A, Ellmark P, Chrisp JS, A Scott M and Christopherson RI (2006) The application of CD antigen proteomics to pharmacogenomics. Pharmacogenomics 7, 759-771. (Abstract)
    25. Persson J and Ohlin M (2006) Antigens for the selection of pan-VNTR (variable number of tandem repeats) motif-specific human antibodies against Mucin-1. J Immunol Methods 316, 116-124. (Abstract)
    26. Wingren C and Borrebaeck CAK (2006) Antibody microarrays: current status and key technological advances. OMICS 10, 411-427. (Abstract)
    27. Arrigoni G, Resjö S, Levander F, Nilsson R, Degerman E, Quadroni M, Pinna L, James P (2006)  Chemical derivatisation of phospho-serine and -threonine containing peptides to increase sensitivity for MALDI based analysis and for selectivity of MS/MS analysis. Proteomics 6, 757-766.
    28. Tibaldi E, Arrigoni G, Brunati AM, James P, Pinna LA (2006) Analysis of a sub-proteome which co-purifies with and is phosphorylated by the Golgi casein kinase. Analysis of a Golgi sub-proteome which co-purifies with a mammary casein kinase activity. Cell Mol Life Sci 63, 378-389. 
    29. Berggård T, Arrigoni G, Fex M, Linse S, James P (2006) 140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res 5, 669-687.
    30. Arrigoni, G.; Fernandez, C.; Holm, C.; Scigelova, M.; James, P.  (2006) Comparison of MS/MS Methods for Protein Identification from 2D-PAGE.  J. Proteome Res.  5, 2294-3000. 
    31. Puricelli L, Iori E, Millioni R, Arrigoni G, James P, Vedovato M, Tessari P (2006) Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J Clin Endocrinol Metab 91, 3507-3514.
    32. James P, Corthals G, Gil C (2006)  Proteomics education, an important challenge for Europe. Proteomics 6 Suppl 2, 77-81.


    1. Steinhauer C, Ressin A, Marko-Varga G, Laurell T, Borrebaeck CAK and Wingren C (2004) Biocompatibility of surfaces for antibody microarrays: Design of macroporous silicon substrates. Anal Biochem  341, 204-213. (Abstract)
    2. Björck E, Ek S, Landgren O, Jerkeman M, Ehinger M, Björkholm M, Borrebaeck CAK, Porwit-Macdonald A and Nordenskjöld M (2005) High expression of cyclin B1 predicts a favorable outcome of patients with follicular lymphoma. Blood 105, 2908-2915. (Abstract)
    3. Wingren C, Steinhauer C, Ingvarsson J, Persson E, Larsson K and Borrebaeck CAK. (2005) Microarrays based on affinity-tagged scFv antibodies: sensitive detection of analyte in complex proteomes. Proteomics 5, 1281-1291. (Abstract)
    4. Lindstedt M, Schiött Å, Johnsen CR, Roggen E, Johansson-Lindbom B and Borrebaeck CAK (2005) Individuals with occupational allergy to detergent enzymes display a differential transcriptional regulation and cellular immune response. Clin Exp Allergy 35, 199-206. (Abstract)
    5. Ek S, Ortega E and Borrebaeck CAK (2005) Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma. Leuk Res 29, 205-213. (Abstract)
    6. Lindstedt M, Schiött Å, Bengtsson A, Larsson K, Korsgren M, Greiff L, Borrebaeck CAK (2005) Genomic and functional delineation of dendritic cells and memory T-cells derived from grass pollen-allergic patients and healthy individuals. Int Immunol 17, 401-409. (Abstract)
    7. Karlsson F, Malmborg-Hager A-M, Albrekt A-S and Borrebaeck CAK (2005) Genome-wide comparison of phage M13 infected vs. uninfected Escherichia coli. Can J Microbiol 51, 29-35. (Abstract)
    8. Persson J, Lantto J, Drakenberg T and Ohlin M (2005) Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicity. Mol Immunol 42, 1321-1330. (Abstract)
    9. Larsson C, Bramfeldt H, Wingren C, Borrebaeck CAK, Höök F (2005) Gravimetric antigen detection utilizing antibody-modified lipid bilayers. Anal Biochem 345, 72-80. (Abstract)
    10. Lindstedt M, Lundberg K and Borrebaeck CAK (2005) Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J Immunol 175, 4839-4846. (Abstract)
    11. Matsusaki M, Larsson K, Akagi T, Lindstedt M, Akashi M, and Borrebaeck CAK (2005) Nanosphere induced gene expression in human dendritic cells. Nano Lett 5, 2168-2173. (Abstract)
    12. Levander F, James P (2005)  Automated protein identification by the combination of MALDI MS and MS/MS spectra from different instruments. J Proteome Res 4, 71-74.
    13. Bäck P,  Bengtsson S, James P (2005) Automated PreScan function for scanning fluorescent 2D gels. J. Proteome Res 4, 1511-1515.
    14. Hagman C,  Ramström M,  Jansson M,  James P,  Håkansson P, Bergquist J (2005)  Reproducibility of tryptic digestion investigated by quantitative Fourier-transform ion cyclotron resonance mass spectrometry. J Proteome Res 4, 394-399.
    15. Johansson BP, Levander F, von Pawel-Rammingen U, Berggård T, Björck L, James P (2005) The protein expression of Streptococcus pyogenes is significantly influenced by human plasma.  J Proteome Res 4, 2302-2311. 
    16. Levander, F and James, P (2005) Mass spectrometry for protein identification. In Proteomics & peptidomics – New technology platforms elucidating biology. (ed. Marko-Varga G). Comprehensive Analytical Chemistry, Elsevier, Amsterdam. vol. 46,  pp. 429-447. 

    Publications 2000-2004

    Publications 1990-1999


    Page Manager: